RGD DISEASE ONTOLOGY - ANNOTATIONS |
|
RGD uses the Human Disease Ontology (DO, https://disease-ontology.org/) for disease curation across species. RGD automatically downloads each new release of the ontology on a monthly basis. Some additional terms which are required for RGD's curation purposes but are not currently covered in the official version of DO have been added. As corresponding terms are added to DO, these custom terms are retired and the DO terms substituted in existing annotations and subsequently used for curation.
|
Term: | Wounds and Injuries |
|
Accession: | DOID:9001600
|
browse the term
|
Definition: | Damage inflicted on the body as the direct or indirect result of an external force, with or without disruption of structural continuity. |
Synonyms: | exact_synonym: | Injuries; Injuries, Wounds; Injury; Injury and Wounds; Research Related Injuries; Research-Related Injury; Trauma; Traumas; Wound; Wounds; Wounds, Injury |
| narrow_synonym: | nose injury |
| primary_id: | MESH:D014947 |
| xref: | EFO:0000546; EFO:0009623 |
| subset: | RGD_JBrowse_slim |
For additional species annotation, visit the
Alliance of Genome Resources.
|
|
|
|
G |
Alox15 |
arachidonate 15-lipoxygenase |
|
ISO |
|
RGD |
PMID:15708862 |
RGD:5509615 |
NCBI chr10:55,060,169...55,068,885
Ensembl chr10:55,060,412...55,068,874
|
|
G |
Ankrd1 |
ankyrin repeat domain 1 |
|
ISO |
mRNA, protein:increased expression:multiple |
RGD |
PMID:15632022 |
RGD:5133280 |
NCBI chr 1:233,815,851...233,834,891
Ensembl chr 1:233,815,851...233,834,919
|
|
G |
Arg1 |
arginase 1 |
|
IEP |
protein:increased expression:wound, fibroblast (rat) |
RGD |
PMID:12069499 |
RGD:634666 |
NCBI chr 1:20,475,878...20,488,422
Ensembl chr 1:20,475,968...20,488,422
|
|
G |
Calca |
calcitonin-related polypeptide alpha |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:18430544 |
|
NCBI chr 1:168,878,212...168,883,176
Ensembl chr 1:168,878,214...168,883,105
|
|
G |
Cxcl1 |
C-X-C motif chemokine ligand 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21192278 |
|
NCBI chr14:17,193,364...17,195,143
Ensembl chr14:17,193,365...17,195,215
|
|
G |
Cxcl12 |
C-X-C motif chemokine ligand 12 |
|
IEP |
mRNA, protein:increased expression:ligament |
RGD |
PMID:19327017 |
RGD:2306564 |
NCBI chr 4:150,388,326...150,401,173
Ensembl chr 4:150,388,325...150,401,168
|
|
G |
Cxcl2 |
C-X-C motif chemokine ligand 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21192278 |
|
NCBI chr14:17,181,030...17,183,075
Ensembl chr14:17,181,062...17,183,075
|
|
G |
Cxcl3 |
C-X-C motif chemokine ligand 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21192278 |
|
NCBI chr14:17,270,146...17,289,458
Ensembl chr14:17,270,146...17,289,511
|
|
G |
Dcn |
decorin |
|
IEP |
|
RGD |
PMID:19393425 |
RGD:2311417 |
NCBI chr 7:32,281,252...32,321,291
Ensembl chr 7:32,281,252...32,321,270
|
|
G |
Egf |
epidermal growth factor |
|
IEP ISO |
CTD Direct Evidence: therapeutic |
CTD RGD |
PMID:21967610 PMID:15885173 |
RGD:6906918 |
NCBI chr 2:218,219,408...218,302,370
Ensembl chr 2:218,219,415...218,302,064
|
|
G |
Eng |
endoglin |
disease_progression |
ISO |
|
RGD |
PMID:23349951 |
RGD:7248769 |
NCBI chr 3:15,934,566...15,972,618
Ensembl chr 3:15,934,518...15,973,230
|
|
G |
Fgf2 |
fibroblast growth factor 2 |
treatment |
ISO IEP |
associated with Diabetes Mellitus, Non-Insulin-Dependent CTD Direct Evidence: therapeutic protein:increased expression:skin |
CTD RGD |
PMID:11842932 PMID:16008728 PMID:21402405 PMID:23603001 PMID:12533868 |
RGD:2315863, RGD:8655582, RGD:8655580, RGD:2292211 |
NCBI chr 2:120,236,328...120,290,673
Ensembl chr 2:120,236,328...120,291,221
|
|
G |
Gc |
GC, vitamin D binding protein |
treatment |
IEP ISO |
associated with Diabetes Mellitus, Experimental CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:17852808 PMID:24263389 |
RGD:11041807 |
NCBI chr14:18,632,146...18,667,563
Ensembl chr14:18,632,135...18,667,567
|
|
G |
Hgf |
hepatocyte growth factor |
treatment |
ISO |
|
RGD |
PMID:16572191 |
RGD:8548635 |
NCBI chr 4:18,673,736...18,745,582
Ensembl chr 4:18,677,101...18,745,409
|
|
G |
Hmox1 |
heme oxygenase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:12649161 |
|
NCBI chr19:13,466,287...13,474,082
Ensembl chr19:13,467,244...13,474,079
|
|
G |
Hp |
haptoglobin |
treatment |
IEP |
protein:increased expression:serum associated with Diabetes Mellitus, Experimental |
RGD |
PMID:11521461 PMID:24263389 |
RGD:1626378, RGD:11041807 |
NCBI chr19:37,539,626...37,544,178
Ensembl chr19:37,539,627...37,544,523
|
|
G |
Icam1 |
intercellular adhesion molecule 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21192278 |
|
NCBI chr 8:19,553,063...19,565,438
Ensembl chr 8:19,553,645...19,565,438
|
|
G |
Igf1 |
insulin-like growth factor 1 |
|
ISO IEP |
associated with Rhinosinusitis; mRNA:increased expression:nose: protein:increased expression:skin: |
RGD |
PMID:20713758 PMID:21296499 |
RGD:8548883, RGD:8549452 |
NCBI chr 7:22,282,895...22,361,972
Ensembl chr 7:22,282,930...22,359,296
|
|
G |
Il10 |
interleukin 10 |
|
IEP |
|
RGD |
PMID:14715528 |
RGD:1598466 |
NCBI chr13:42,472,625...42,477,308
Ensembl chr13:42,472,839...42,477,313
|
|
G |
Il1a |
interleukin 1 alpha |
|
IEP |
|
RGD |
PMID:18638276 |
RGD:2311088 |
NCBI chr 3:116,526,601...116,537,055
Ensembl chr 3:116,526,604...116,536,822
|
|
G |
Il6 |
interleukin 6 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21192278 |
|
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
|
|
G |
Lama3 |
laminin subunit alpha 3 |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:15541073 |
|
NCBI chr18:3,523,168...3,751,722
Ensembl chr18:3,523,133...3,751,353
|
|
G |
Lamb3 |
laminin subunit beta 3 |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:15541073 |
|
NCBI chr13:104,833,810...104,875,405
Ensembl chr13:104,833,873...104,875,405
|
|
G |
Lamc2 |
laminin subunit gamma 2 |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:15541073 |
|
NCBI chr13:65,284,664...65,344,200
Ensembl chr13:65,284,664...65,344,200
|
|
G |
Ltf |
lactotransferrin |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:16640825 |
|
NCBI chr 8:110,999,948...111,022,795
Ensembl chr 8:110,999,948...111,022,795
|
|
G |
Lum |
lumican |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:24367547 |
|
NCBI chr 7:32,358,990...32,365,794
Ensembl chr 7:32,358,614...32,365,793
|
|
G |
Mmp7 |
matrix metallopeptidase 7 |
|
IEP |
|
RGD |
PMID:9888422 |
RGD:9685353 |
NCBI chr 8:4,848,186...4,855,908
Ensembl chr 8:4,848,186...4,855,902
|
|
G |
Mmp8 |
matrix metallopeptidase 8 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:11172683 |
|
NCBI chr 8:4,724,009...4,732,956
Ensembl chr 8:4,724,029...4,733,520
|
|
G |
Mpo |
myeloperoxidase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21192278 |
|
NCBI chr10:72,594,458...72,608,862
Ensembl chr10:72,594,661...72,604,819
|
|
G |
Oprl1 |
opioid related nociceptin receptor 1 |
|
IEP |
protein:decreased expression:hypothalamus: |
RGD |
PMID:11931711 |
RGD:9835019 |
NCBI chr 3:168,831,934...168,839,920
Ensembl chr 3:168,834,003...168,839,920
|
|
G |
Optn |
optineurin |
|
IEP |
|
RGD |
PMID:16109995 |
RGD:7775038 |
NCBI chr17:73,209,572...73,260,251
Ensembl chr17:73,209,575...73,260,251
|
|
G |
Pdgfa |
platelet derived growth factor subunit A |
|
IEP |
|
RGD |
PMID:18205704 |
RGD:2292158 |
NCBI chr12:15,645,549...15,667,056
Ensembl chr12:15,645,541...15,666,497
|
|
G |
Pdgfb |
platelet derived growth factor subunit B |
treatment |
IEP ISO |
protein:increased expression:skin |
RGD |
PMID:12533868 PMID:3280728 |
RGD:2292211, RGD:10449501 |
NCBI chr 7:111,539,444...111,557,984
Ensembl chr 7:111,540,345...111,557,984
|
|
G |
Pdgfrb |
platelet derived growth factor receptor beta |
|
IEP |
protein:increased expression:skin |
RGD |
PMID:12533868 |
RGD:2292211 |
NCBI chr18:54,500,002...54,538,843
Ensembl chr18:54,499,964...54,538,843
|
|
G |
Plat |
plasminogen activator, tissue type |
|
IEP |
protein:increased expression:plasma (rat) |
RGD |
PMID:25423126 |
RGD:11541076 |
NCBI chr16:69,240,582...69,265,177
Ensembl chr16:69,240,585...69,268,223
|
|
G |
Pnoc |
prepronociceptin |
|
IEP |
protein:decreased expression:hypothalamus: |
RGD |
PMID:11931711 |
RGD:9835019 |
NCBI chr15:39,624,635...39,652,463
Ensembl chr15:39,624,641...39,651,867
|
|
G |
Postn |
periostin |
|
IEP |
protein:increased expression:skin: |
RGD |
PMID:22681660 |
RGD:10040991 |
NCBI chr 2:138,527,714...138,559,098
Ensembl chr 2:138,527,696...138,559,099
|
|
G |
Sparc |
secreted protein acidic and cysteine rich |
|
IEP |
mRNA, protein:increased expression:skin, fibroblast |
RGD |
PMID:8245406 |
RGD:2300076 |
NCBI chr10:39,516,394...39,538,252
Ensembl chr10:39,516,406...39,538,396
|
|
G |
Spp1 |
secreted phosphoprotein 1 |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:9525990 |
|
NCBI chr14:5,308,885...5,315,120
Ensembl chr14:5,308,885...5,315,162
|
|
G |
Tgfb1 |
transforming growth factor, beta 1 |
|
IEP IMP |
protein:increased expression:skin |
RGD |
PMID:12533868 PMID:17117936 |
RGD:2292211, RGD:2302090 |
NCBI chr 1:81,196,532...81,212,848
Ensembl chr 1:81,196,532...81,212,847
|
|
G |
Tgfb2 |
transforming growth factor, beta 2 |
|
IMP IEP |
|
RGD |
PMID:17117936 PMID:18205704 |
RGD:2302090, RGD:2292158 |
NCBI chr13:98,160,075...98,261,771
Ensembl chr13:98,160,087...98,261,405
|
|
G |
Tgfb3 |
transforming growth factor, beta 3 |
|
IEP |
|
RGD |
PMID:18205704 |
RGD:2292158 |
NCBI chr 6:105,704,058...105,726,661
Ensembl chr 6:105,704,236...105,726,564
|
|
G |
Timp1 |
TIMP metallopeptidase inhibitor 1 |
|
IEP |
mRNA, protein:increased expression:dorsal root ganglion |
RGD |
PMID:16683235 |
RGD:1600154 |
NCBI chr X:1,212,969...1,217,714
Ensembl chr X:1,212,972...1,217,664
|
|
G |
Timp4 |
TIMP metallopeptidase inhibitor 4 |
|
IEP |
mRNA, protein:increased expression:carotid artery |
RGD |
PMID:10082471 |
RGD:2290470 |
NCBI chr 4:148,306,021...148,312,558
Ensembl chr 4:148,304,490...148,312,558
|
|
G |
Tnf |
tumor necrosis factor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21192278 |
|
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
|
|
G |
Vegfa |
vascular endothelial growth factor A |
treatment |
ISO |
|
RGD |
PMID:23603001 |
RGD:8655580 |
NCBI chr 9:14,955,300...14,970,641
Ensembl chr 9:14,955,300...14,970,641
|
|
|
G |
Mfn1 |
mitofusin 1 |
|
IEP |
mRNA, protein:increased expression:heart (rat) |
RGD |
PMID:25677476 |
RGD:12437078 |
NCBI chr 2:115,313,380...115,359,651
Ensembl chr 2:115,313,401...115,359,640
|
|
|
G |
Ace |
angiotensin I converting enzyme |
treatment |
ISO |
associated wit Escherichia coli Infections |
RGD |
PMID:29990483 |
RGD:40400897 |
NCBI chr10:90,910,316...90,930,437
Ensembl chr10:90,910,316...90,931,131
|
|
G |
Ace2 |
angiotensin I converting enzyme 2 |
severity treatment |
ISO |
CTD Direct Evidence: therapeutic associated with Escherichia coli Infections associated with avian influenza;protein:decreased expression:lung (mouse) human protein in a mouse model |
CTD RGD |
PMID:27302421 PMID:16001071 PMID:29990483 PMID:25391767 PMID:16001071 |
RGD:32716389, RGD:40400897, RGD:40818412, RGD:32716389 |
NCBI chr X:30,293,597...30,340,961
Ensembl chr X:30,293,589...30,340,977
|
|
G |
Acvr1 |
activin A receptor type 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21297076 |
|
NCBI chr 3:42,978,558...43,097,892
Ensembl chr 3:42,978,561...43,098,241
|
|
G |
Adar |
adenosine deaminase, RNA-specific |
treatment |
IMP |
|
RGD |
PMID:18520702 |
RGD:10755331 |
NCBI chr 2:175,138,391...175,178,280
Ensembl chr 2:175,138,403...175,178,282
|
|
G |
Adipoq |
adiponectin, C1Q and collagen domain containing |
treatment |
ISO |
associated with Sepsis |
RGD |
PMID:22156343 PMID:23522481 |
RGD:5686380, RGD:8695940 |
NCBI chr11:77,721,912...77,735,644
Ensembl chr11:77,721,912...77,735,564
|
|
G |
Adra2a |
adrenoceptor alpha 2A |
|
IEP |
|
RGD |
PMID:21542970 |
RGD:6480481 |
NCBI chr 1:253,061,480...253,064,280
Ensembl chr 1:253,060,218...253,064,365
|
|
G |
Aff4 |
ALF transcription elongation factor 4 |
treatment |
IEP |
|
RGD |
PMID:31466050 |
RGD:155631268 |
NCBI chr10:37,498,825...37,579,751
Ensembl chr10:37,498,825...37,579,751
|
|
G |
Ager |
advanced glycosylation end product-specific receptor |
|
IEP |
associated with Hyperoxia; protein:decreased expression:bronchoalveolar lavage fluid (rat) |
RGD |
PMID:23576805 |
RGD:7244254 |
NCBI chr20:4,148,150...4,151,361
Ensembl chr20:4,147,890...4,151,078
|
|
G |
Akap12 |
A-kinase anchoring protein 12 |
|
IEP |
mRNA,protein:increased expression:lung |
RGD |
PMID:23912647 |
RGD:14348970 |
NCBI chr 1:40,730,123...40,819,863
Ensembl chr 1:40,730,123...40,819,886
|
|
G |
Akt1 |
AKT serine/threonine kinase 1 |
severity |
ISO |
|
RGD |
PMID:23904165 |
RGD:38676478 |
NCBI chr 6:131,713,716...131,735,319
Ensembl chr 6:131,713,720...131,733,921
|
|
G |
Alb |
albumin |
|
IDA |
|
RGD |
PMID:22592748 |
RGD:6483494 |
NCBI chr14:17,607,397...17,622,814
Ensembl chr14:17,607,381...17,622,836
|
|
G |
Alox15 |
arachidonate 15-lipoxygenase |
|
ISO |
|
RGD |
PMID:19752233 |
RGD:5509626 |
NCBI chr10:55,060,169...55,068,885
Ensembl chr10:55,060,412...55,068,874
|
|
G |
Apoa1 |
apolipoprotein A1 |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:20972769 |
|
NCBI chr 8:46,527,251...46,529,035
Ensembl chr 8:46,527,144...46,529,035
|
|
G |
Aqp5 |
aquaporin 5 |
|
IEP |
associated with Disseminated Intravascular Coagulation;mRNA,protein:decreased expression:lung: |
RGD |
PMID:24806323 |
RGD:11553933 |
NCBI chr 7:130,722,675...130,726,207
Ensembl chr 7:130,721,748...130,726,209
|
|
G |
Ascl1 |
achaete-scute family bHLH transcription factor 1 |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:20554700 |
|
NCBI chr 7:21,904,153...21,906,003
Ensembl chr 7:21,903,126...21,905,993
|
|
G |
Bax |
BCL2 associated X, apoptosis regulator |
|
IEP |
associated with Endotoxemia |
RGD |
PMID:20663300 |
RGD:10054109 |
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
|
|
G |
Bcl2 |
BCL2, apoptosis regulator |
|
IEP |
associated with Endotoxemia |
RGD |
PMID:20663300 |
RGD:10054109 |
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
|
|
G |
C3 |
complement C3 |
treatment |
IEP |
|
RGD |
PMID:22763771 |
RGD:11040808 |
NCBI chr 9:2,087,437...2,114,366
Ensembl chr 9:2,087,437...2,114,429
|
|
G |
Casp12 |
caspase 12 |
treatment |
IEP |
associated with Crush Injuries |
RGD |
PMID:30465396 |
RGD:34901874 |
NCBI chr 8:2,642,296...2,669,549
Ensembl chr 8:2,642,434...2,674,037
|
|
G |
Casp3 |
caspase 3 |
treatment |
IEP ISO |
CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:32062619 PMID:29755641 |
RGD:13782288 |
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
|
|
G |
Casp8 |
caspase 8 |
treatment |
IEP |
|
RGD |
PMID:29755641 |
RGD:13782288 |
NCBI chr 9:60,263,863...60,312,542
Ensembl chr 9:60,264,075...60,312,542
|
|
G |
Cat |
catalase |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:15612528 |
|
NCBI chr 3:89,842,393...89,874,577
Ensembl chr 3:89,842,399...89,874,478
|
|
G |
Cav1 |
caveolin 1 |
treatment |
IEP |
|
RGD |
PMID:24919947 |
RGD:10045573 |
NCBI chr 4:45,640,624...45,673,708
Ensembl chr 4:45,634,918...45,673,705
|
|
G |
Ccl2 |
C-C motif chemokine ligand 2 |
|
IEP |
mRNA, protein:increased expression:lung |
RGD |
PMID:21767135 |
RGD:6480432 |
NCBI chr10:67,005,424...67,007,222
Ensembl chr10:67,005,424...67,007,226
|
|
G |
Ccl4 |
C-C motif chemokine ligand 4 |
|
IMP IEP ISO |
mRNA, protein:increased expression:lung protein:increased expression:respiratory system fluid/secretion |
RGD |
PMID:10679105 PMID:21767135 PMID:21906407 |
RGD:68880, RGD:6480432, RGD:5683874 |
NCBI chr10:68,466,469...68,467,941
Ensembl chr10:68,452,052...68,468,231
|
|
G |
Ccr1 |
C-C motif chemokine receptor 1 |
|
ISO |
associated with Pancreatitis |
RGD |
PMID:17312463 |
RGD:5688151 |
NCBI chr 8:123,556,286...123,561,841
|
|
G |
Cd36 |
CD36 molecule |
|
ISO |
associated with Malaria |
RGD |
PMID:18483551 |
RGD:6893505 |
NCBI chr 4:17,317,343...17,410,084
Ensembl chr 4:17,354,466...17,513,903
|
|
G |
Cxcl1 |
C-X-C motif chemokine ligand 1 |
|
ISO |
associated with Sepsis;mRNA:increased expression:lung |
RGD |
PMID:10069420 |
RGD:5135253 |
NCBI chr14:17,193,364...17,195,143
Ensembl chr14:17,193,365...17,195,215
|
|
G |
Cxcl2 |
C-X-C motif chemokine ligand 2 |
|
ISO IEP |
mRNA, protein:increased expression:lung CTD Direct Evidence: marker/mechanism protein:increased expression:respiratory system fluid/secretion associated with Sepsis;mRNA:increased expression:lung |
CTD RGD |
PMID:27525872 PMID:15557650 PMID:19106808 PMID:10069420 |
RGD:5135247, RGD:5147925, RGD:5135253 |
NCBI chr14:17,181,030...17,183,075
Ensembl chr14:17,181,062...17,183,075
|
|
G |
Cxcl6 |
C-X-C motif chemokine ligand 6 |
|
ISO IMP |
mRNA, protein:increased expression:lung associated with Reperfusion Injury |
RGD |
PMID:15557650 PMID:7814607 |
RGD:5135247, RGD:5135256 |
NCBI chr14:17,310,089...17,312,303
Ensembl chr14:17,310,426...17,313,093
|
|
G |
Cxcr2 |
C-X-C motif chemokine receptor 2 |
treatment |
ISO |
associated with Pancreatitis |
RGD |
PMID:17014919 |
RGD:7257703 |
NCBI chr 9:75,729,493...75,735,868
Ensembl chr 9:75,729,115...75,739,425
|
|
G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
ISO IEP |
mRNA:increased expression:lung |
RGD |
PMID:18367723 PMID:16882535 |
RGD:5135235, RGD:5147744 |
NCBI chr 8:58,096,021...58,102,130
Ensembl chr 8:58,096,077...58,102,125
|
|
G |
Cyp2b1 |
cytochrome P450, family 2, subfamily b, polypeptide 1 |
|
IEP |
|
RGD |
PMID:16882535 |
RGD:5147744 |
NCBI chr 1:81,518,387...81,544,999
Ensembl chr 1:81,518,408...81,542,052
|
|
G |
Cysltr1 |
cysteinyl leukotriene receptor 1 |
treatment |
ISO |
associated with Endotoxemia |
RGD |
PMID:27703200 |
RGD:40903067 |
NCBI chr X:71,661,415...71,690,158
Ensembl chr X:71,663,821...71,690,121
|
|
G |
Ddit3 |
DNA-damage inducible transcript 3 |
treatment |
IEP |
associated with Crush Injuries |
RGD |
PMID:30465396 |
RGD:34901874 |
NCBI chr 7:63,115,645...63,121,203
Ensembl chr 7:63,116,380...63,121,201
|
|
G |
Edn1 |
endothelin 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16625121 |
|
NCBI chr17:22,454,924...22,460,812
Ensembl chr17:22,454,420...22,460,885
|
|
G |
Egfr |
epidermal growth factor receptor |
|
ISO |
|
RGD |
PMID:20935109 |
RGD:5131862 |
NCBI chr14:91,176,931...91,349,722
Ensembl chr14:91,177,067...91,344,382
|
|
G |
Elane |
elastase, neutrophil expressed |
treatment |
IMP IEP |
associated with Shock, Hemorrhagic; protein:increased expression:perfusate: |
RGD |
PMID:15257085 PMID:17203197 PMID:18283562 |
RGD:10450548, RGD:10450587, RGD:10450585 |
NCBI chr 7:9,817,251...9,819,174
Ensembl chr 7:9,817,252...9,819,100
|
|
G |
Ephx1 |
epoxide hydrolase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:26840748 |
|
NCBI chr13:92,714,315...92,744,124
Ensembl chr13:92,714,315...92,790,235
|
|
G |
Ephx2 |
epoxide hydrolase 2 |
|
IDA |
|
RGD |
PMID:22051199 |
RGD:5688354 |
NCBI chr15:40,289,901...40,327,632
Ensembl chr15:40,289,902...40,327,615
|
|
G |
Ern1 |
endoplasmic reticulum to nucleus signaling 1 |
treatment |
IEP |
associated with Crush Injuries |
RGD |
PMID:30465396 |
RGD:34901874 |
NCBI chr10:91,326,889...91,421,201
Ensembl chr10:91,330,654...91,421,029
|
|
G |
F2 |
coagulation factor II |
|
IDA |
|
RGD |
PMID:22804886 |
RGD:7387313 |
NCBI chr 3:77,596,196...77,609,486
Ensembl chr 3:77,596,198...77,609,486
|
|
G |
F3 |
coagulation factor III, tissue factor |
|
IEP |
protein:increased expression: respiratory system fluid/secretion |
RGD |
PMID:21964405 |
RGD:11341740 |
NCBI chr 2:209,827,061...209,838,666
Ensembl chr 2:209,826,959...209,838,668
|
|
G |
Fadd |
Fas associated via death domain |
treatment |
IEP |
associated with Shock, Hemorrhagic |
RGD |
PMID:24122010 |
RGD:11341811 |
NCBI chr 1:199,743,200...199,745,746
Ensembl chr 1:199,739,994...199,745,653
|
|
G |
Fas |
Fas cell surface death receptor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:11778176 |
|
NCBI chr 1:231,798,963...231,832,591
Ensembl chr 1:231,798,960...231,832,591
|
|
G |
Faslg |
Fas ligand |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:11778176 |
|
NCBI chr13:74,151,519...74,172,760
Ensembl chr13:74,154,954...74,162,215
|
|
G |
Fcgr1a |
Fc gamma receptor 1A |
|
IMP |
|
RGD |
PMID:19106808 |
RGD:5147925 |
NCBI chr 2:183,851,075...183,860,077
Ensembl chr 2:183,851,077...183,859,994
|
|
G |
Fcgr2a |
Fc gamma receptor 2A |
|
IMP |
|
RGD |
PMID:19106808 |
RGD:5147925 |
NCBI chr13:83,280,782...83,297,535
Ensembl chr13:83,280,784...83,295,967
|
|
G |
Fcgr2b |
Fc gamma receptor 2B |
treatment |
IMP |
|
RGD |
PMID:19106808 |
RGD:5147925 |
NCBI chr13:83,191,253...83,207,776
Ensembl chr13:83,193,163...83,207,778
|
|
G |
Fga |
fibrinogen alpha chain |
|
IEP |
protein:increased expression:blood (rat) |
RGD |
PMID:22804886 |
RGD:7387313 |
NCBI chr 2:168,365,364...168,381,533
Ensembl chr 2:168,374,120...168,381,528
|
|
G |
Flt1 |
Fms related receptor tyrosine kinase 1 |
|
IMP |
associated with Endotoxemia |
RGD |
PMID:21528367 |
RGD:5684427 |
NCBI chr12:7,296,899...7,468,626
Ensembl chr12:7,297,292...7,468,626
|
|
G |
Foxa1 |
forkhead box A1 |
|
IEP |
mRNA,protein:increased expression:lung |
RGD |
PMID:19649697 |
RGD:151665511 |
NCBI chr 6:75,099,907...75,136,534
Ensembl chr 6:75,103,503...75,136,188
|
|
G |
Gja1 |
gap junction protein, alpha 1 |
treatment |
IEP |
|
RGD |
PMID:23576849 |
RGD:8662452 |
NCBI chr20:35,756,007...35,768,481
Ensembl chr20:35,755,991...35,768,582
|
|
G |
Got1 |
glutamic-oxaloacetic transaminase 1 |
|
IEP |
protein:decreased expression:lung (rat) |
RGD |
PMID:25581610 |
RGD:13504847 |
NCBI chr 1:242,357,293...242,381,535
Ensembl chr 1:242,357,306...242,380,633
|
|
G |
Gsr |
glutathione-disulfide reductase |
|
IEP |
|
RGD |
PMID:7896613 |
RGD:7257562 |
NCBI chr16:58,482,209...58,525,256
Ensembl chr16:58,482,505...58,525,661
|
|
G |
Gzmb |
granzyme B |
|
ISO |
|
RGD |
PMID:20018616 |
RGD:5135517 |
NCBI chr15:30,343,361...30,346,792
Ensembl chr15:30,173,603...30,346,814
|
|
G |
Hmgb1 |
high mobility group box 1 |
treatment |
IEP |
associated with Endotoxemia associated with Crush Injuries associated with Burns |
RGD |
PMID:19766246 PMID:30465396 PMID:23874764 |
RGD:4892587, RGD:34901874, RGD:10402098 |
NCBI chr12:5,973,062...5,978,565
Ensembl chr12:5,901,586...5,978,565
|
|
G |
Hmgcr |
3-hydroxy-3-methylglutaryl-CoA reductase |
|
ISO |
|
RGD |
PMID:16922808 |
RGD:5508470 |
NCBI chr 2:27,997,523...28,018,983
Ensembl chr 2:27,997,525...28,019,703
|
|
G |
Hmox1 |
heme oxygenase 1 |
treatment |
IMP IEP |
associated with Reperfusion Injury |
RGD |
PMID:20850789 PMID:20360627 |
RGD:4145326, RGD:4140418 |
NCBI chr19:13,466,287...13,474,082
Ensembl chr19:13,467,244...13,474,079
|
|
G |
Hnrnpc |
heterogeneous nuclear ribonucleoprotein C |
|
ISO |
protein:altered localization:lung (mouse) |
RGD |
PMID:19029002 |
RGD:10054390 |
NCBI chr15:24,779,593...24,809,213
Ensembl chr15:24,779,450...24,809,183
|
|
G |
Hspa5 |
heat shock protein family A (Hsp70) member 5 |
treatment |
IEP |
associated with Crush Injuries |
RGD |
PMID:30465396 |
RGD:34901874 |
NCBI chr 3:18,055,507...18,059,969
Ensembl chr 3:18,055,405...18,059,891
|
|
G |
Icam1 |
intercellular adhesion molecule 1 |
treatment |
IEP ISO |
CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:17973899 PMID:27525872 PMID:20569121 |
RGD:8547719 |
NCBI chr 8:19,553,063...19,565,438
Ensembl chr 8:19,553,645...19,565,438
|
|
G |
Ido1 |
indoleamine 2,3-dioxygenase 1 |
treatment |
ISO |
|
RGD |
PMID:25278421 |
RGD:39939031 |
NCBI chr16:67,430,684...67,442,459
Ensembl chr16:67,430,578...67,442,730
|
|
G |
Ifng |
interferon gamma |
|
IEP |
|
RGD |
PMID:21767135 |
RGD:6480432 |
NCBI chr 7:53,903,339...53,907,375
Ensembl chr 7:53,903,337...53,907,375
|
|
G |
Il10 |
interleukin 10 |
treatment no_association |
IDA ISO IEP |
DNA:SNP:promoter:rs3021097 (human) DNA:SNP:promoter:-1082G>A (rs1800896) (human) associated with Reperfusion Injury;protein:increased expression:lung, plasma |
RGD |
PMID:23902576 PMID:30412745 PMID:30412745 PMID:23801594 |
RGD:7364984, RGD:14975158, RGD:14975158, RGD:7365008 |
NCBI chr13:42,472,625...42,477,308
Ensembl chr13:42,472,839...42,477,313
|
|
G |
Il13 |
interleukin 13 |
|
IEP |
mRNA:increased expression:lung |
RGD |
PMID:15461830 |
RGD:4145512 |
NCBI chr10:37,790,130...37,792,687
Ensembl chr10:37,790,130...37,792,737
|
|
G |
Il17a |
interleukin 17A |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28600744 |
|
NCBI chr 9:23,144,402...23,147,889
Ensembl chr 9:23,144,402...23,147,889
|
|
G |
Il18 |
interleukin 18 |
treatment |
IEP |
associated with Myocardial Reperfusion Injury |
RGD |
PMID:24223666 |
RGD:8655952 |
NCBI chr 8:50,904,630...50,932,887
Ensembl chr 8:50,906,960...50,932,887
|
|
G |
Il1b |
interleukin 1 beta |
|
ISO IDA IEP |
protein:increased expression:lung CTD Direct Evidence: marker/mechanism mRNA, protein:increased expression:lung protein:increased expression:serum |
CTD RGD |
PMID:32062619 PMID:20153312 PMID:22982561 PMID:21767135 PMID:20663306 PMID:8613550 More...
|
RGD:4142807, RGD:7204498, RGD:6480432, RGD:4142531, RGD:4143193 |
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
|
|
G |
Il1rl1 |
interleukin 1 receptor-like 1 |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD RGD |
PMID:21352201 PMID:21352201 |
RGD:5144222 |
NCBI chr 9:42,661,694...42,727,266
Ensembl chr 9:42,697,192...42,727,256
|
|
G |
Il1rn |
interleukin 1 receptor antagonist |
|
IMP IEP |
mRNA:increased expression:lung |
RGD |
PMID:8613550 PMID:15970097 |
RGD:4143193, RGD:4143168 |
NCBI chr 3:7,111,567...7,127,451
Ensembl chr 3:7,111,550...7,127,445
|
|
G |
Il2 |
interleukin 2 |
|
IEP |
protein:increased expression:respiratory system fluid/secretion |
RGD |
PMID:21767135 |
RGD:6480432 |
NCBI chr 2:120,004,862...120,009,566
Ensembl chr 2:120,004,862...120,009,566
|
|
G |
Il22 |
interleukin 22 |
|
ISO |
|
RGD |
PMID:20498020 |
RGD:4888524 |
NCBI chr 7:53,801,206...53,805,673
Ensembl chr 7:53,801,206...53,806,186
|
|
G |
Il4 |
interleukin 4 |
treatment |
IEP |
|
RGD |
PMID:24681349 |
RGD:10402798 |
NCBI chr10:37,771,203...37,776,750
Ensembl chr10:37,771,203...37,776,750
|
|
G |
Il6 |
interleukin 6 |
|
IEP ISO |
protein:increased expression:bronchoalveolar lavage, blood, lung (rat) CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:32062619 PMID:19995278 |
RGD:11062103 |
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
|
|
G |
Irak3 |
interleukin-1 receptor-associated kinase 3 |
|
ISO |
mRNA, protein:increased expression:lung (mouse) |
RGD |
PMID:21577093 |
RGD:36049795 |
NCBI chr 7:55,653,949...55,714,371
Ensembl chr 7:55,653,962...55,713,121
|
|
G |
Itgb2 |
integrin subunit beta 2 |
|
IMP |
|
RGD |
PMID:1374449 |
RGD:6482199 |
NCBI chr20:11,061,394...11,097,656
Ensembl chr20:11,061,430...11,097,600
|
|
G |
Jak3 |
Janus kinase 3 |
|
ISO |
|
RGD |
PMID:22359619 |
RGD:11531100 |
NCBI chr16:18,386,330...18,398,542
Ensembl chr16:18,386,405...18,398,536
|
|
G |
Kdr |
kinase insert domain receptor |
|
IEP |
associated with Endotoxemia;mRNA, protein:decreased expression:lung |
RGD |
PMID:21528367 |
RGD:5684427 |
NCBI chr14:32,217,871...32,261,018
Ensembl chr14:32,217,871...32,261,018
|
|
G |
Ltb4r2 |
leukotriene B4 receptor 2 |
severity |
ISO |
associated with Endotoxemia |
RGD |
PMID:27703200 |
RGD:40903067 |
NCBI chr15:29,258,427...29,260,340
Ensembl chr15:29,259,240...29,260,316
|
|
G |
Mfn1 |
mitofusin 1 |
|
IEP |
mRNA, protein:altered expression:lung (rat) |
RGD |
PMID:25560372 |
RGD:12437080 |
NCBI chr 2:115,313,380...115,359,651
Ensembl chr 2:115,313,401...115,359,640
|
|
G |
Mfn2 |
mitofusin 2 |
|
IEP |
mRNA, protein:increased expression:lung (rat) |
RGD |
PMID:25560372 |
RGD:12437080 |
NCBI chr 5:158,304,285...158,335,502
Ensembl chr 5:158,304,287...158,335,342
|
|
G |
Mir155 |
microRNA 155 |
treatment |
ISO IMP |
associated with sepsis;miRNA:increased expression:lung associated with Sepsis |
RGD |
PMID:30220274 PMID:27371731 PMID:27371731 PMID:28125526 PMID:31949845 |
RGD:21066348, RGD:11566124, RGD:11566124, RGD:24922218, RGD:21408593 |
NCBI chr11:23,774,654...23,774,718
Ensembl chr11:23,774,654...23,774,718
|
|
G |
Mir21 |
microRNA 21 |
|
IEP |
RNA:increased expression:lung |
RGD |
PMID:30542412 |
RGD:41410885 |
NCBI chr10:71,405,257...71,405,348
Ensembl chr10:71,405,257...71,405,348
|
|
G |
Mir223 |
microRNA 223 |
severity treatment |
ISO IEP |
|
RGD |
PMID:28931657 PMID:32226458 |
RGD:21408568, RGD:26884341 |
NCBI chr X:61,141,887...61,141,996
Ensembl chr X:61,141,887...61,141,996
|
|
G |
Mir330 |
microRNA 330 |
|
IEP |
associated with Disseminated Intravascular Coagulation;RNA:increased expression:lung: |
RGD |
PMID:24806323 |
RGD:11553933 |
NCBI chr 1:78,833,178...78,833,274
Ensembl chr 1:78,833,178...78,833,274
|
|
G |
Mir96 |
microRNA 96 |
|
IEP |
associated with Disseminated Intravascular Coagulation;RNA:increased expression:lung: |
RGD |
PMID:24806323 |
RGD:11553933 |
NCBI chr 4:58,788,411...58,788,516
Ensembl chr 4:58,788,411...58,788,516
|
|
G |
Mir99b |
microRNA 99b |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:33109608 |
|
NCBI chr 1:58,677,015...58,677,084
Ensembl chr 1:58,677,011...58,677,090
|
|
G |
Mmp2 |
matrix metallopeptidase 2 |
|
IEP |
|
RGD |
PMID:23040778 |
RGD:13207316 |
NCBI chr19:14,154,657...14,182,870
Ensembl chr19:14,154,657...14,182,870
|
|
G |
Mmp7 |
matrix metallopeptidase 7 |
|
IEP |
associated with Sepsis |
RGD |
PMID:21567117 |
RGD:9685338 |
NCBI chr 8:4,848,186...4,855,908
Ensembl chr 8:4,848,186...4,855,902
|
|
G |
Mmp9 |
matrix metallopeptidase 9 |
|
IEP |
|
RGD |
PMID:23040778 |
RGD:13207316 |
NCBI chr 3:153,684,158...153,692,118
Ensembl chr 3:153,683,858...153,692,120
|
|
G |
Mpo |
myeloperoxidase |
|
ISO |
associated with Kidney Reperfusion Injury; protein:increased expression:lung |
RGD |
PMID:22092133 |
RGD:6909173 |
NCBI chr10:72,594,458...72,608,862
Ensembl chr10:72,594,661...72,604,819
|
|
G |
Mt2A |
metallothionein 2A |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16166738 |
|
NCBI chr19:10,832,009...10,832,783
Ensembl chr19:10,832,002...10,832,784
|
|
G |
Mylk |
myosin light chain kinase |
|
ISO |
associated with Sepsis CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:19374788 PMID:16399953 |
RGD:1581052 |
NCBI chr11:65,783,008...66,030,239
Ensembl chr11:65,783,008...66,030,261
|
|
G |
Nfe2l2 |
NFE2 like bZIP transcription factor 2 |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:24812154 |
|
NCBI chr 3:60,594,239...60,621,785
Ensembl chr 3:60,594,242...60,621,737
|
|
G |
Ngf |
nerve growth factor |
|
ISO |
|
RGD |
PMID:17673270 |
RGD:5144065 |
NCBI chr 2:189,901,058...189,954,452
Ensembl chr 2:189,901,058...189,954,452
|
|
G |
Nlrp3 |
NLR family, pyrin domain containing 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:33012731 |
|
NCBI chr10:44,326,770...44,353,814
Ensembl chr10:44,328,566...44,352,811
|
|
G |
Nod2 |
nucleotide-binding oligomerization domain containing 2 |
treatment |
IDA |
associated with Sepsis |
RGD |
PMID:22575870 |
RGD:8547530 |
NCBI chr19:18,379,720...18,422,817
Ensembl chr19:18,382,439...18,417,177
|
|
G |
Nos2 |
nitric oxide synthase 2 |
|
IMP |
|
RGD |
PMID:16882535 |
RGD:5147744 |
NCBI chr10:63,815,308...63,851,208
Ensembl chr10:63,815,308...63,851,210
|
|
G |
Nppa |
natriuretic peptide A |
|
ISO |
|
RGD |
PMID:23422200 |
RGD:7247713 |
NCBI chr 5:158,429,042...158,430,351
Ensembl chr 5:158,429,042...158,430,351
|
|
G |
Nqo1 |
NAD(P)H quinone dehydrogenase 1 |
treatment |
IEP IDA |
|
RGD |
PMID:24669282 PMID:28065220 |
RGD:11035223, RGD:13442501 |
NCBI chr19:35,295,633...35,310,528
Ensembl chr19:35,295,573...35,310,557
|
|
G |
Opa1 |
OPA1, mitochondrial dynamin like GTPase |
|
IEP |
mRNA, protein:altered expression:lung (rat) |
RGD |
PMID:25560372 |
RGD:12437080 |
NCBI chr11:71,108,100...71,185,170
Ensembl chr11:71,109,873...71,185,109
|
|
G |
P2ry12 |
purinergic receptor P2Y12 |
|
IMP |
associated with Shock, Hemorrhagic |
RGD |
PMID:21841533 |
RGD:6480522 |
NCBI chr 2:143,481,468...143,523,340
Ensembl chr 2:143,481,430...143,523,361
|
|
G |
Pak1 |
p21 (RAC1) activated kinase 1 |
|
IDA |
DNA:hypermethylation |
RGD |
PMID:23546543 |
RGD:11533951 |
NCBI chr 1:152,111,172...152,226,390
Ensembl chr 1:152,111,188...152,226,383
|
|
G |
Parp1 |
poly (ADP-ribose) polymerase 1 |
|
ISO |
associated with Pancreatitis, Experimental, Acute |
RGD |
PMID:16127429 |
RGD:11075069 |
NCBI chr13:92,307,593...92,339,406
Ensembl chr13:92,307,586...92,339,404
|
|
G |
Pawr |
pro-apoptotic WT1 regulator |
|
IEP |
mRNA,protein:increased expression:lung,blood vessel: |
RGD |
PMID:17136598 |
RGD:9835397 |
NCBI chr 7:43,645,028...43,725,033
Ensembl chr 7:43,645,084...43,725,028
|
|
G |
Pecam1 |
platelet and endothelial cell adhesion molecule 1 |
|
IDA |
|
RGD |
PMID:22592748 |
RGD:6483494 |
NCBI chr10:91,590,521...91,652,279
Ensembl chr10:91,590,521...91,652,116
|
|
G |
Pfkfb3 |
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3 |
|
ISO |
associated with Endotoxemia;mRNA, protein:increased expression:lung (mouse) |
RGD |
PMID:31167111 |
RGD:41410778 |
NCBI chr17:66,983,629...67,064,702
Ensembl chr17:66,983,686...67,063,125
|
|
G |
Pik3cg |
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma |
|
ISO |
associated with endotoxemia |
RGD |
PMID:22198681 PMID:11714830 |
RGD:6482677, RGD:38599213 |
NCBI chr 6:48,766,778...48,802,098
Ensembl chr 6:48,766,864...48,802,043
|
|
G |
Pla2g2a |
phospholipase A2 group IIA |
severity |
IEP |
|
RGD |
PMID:19235614 |
RGD:6482722 |
NCBI chr 5:151,076,442...151,079,019
Ensembl chr 5:151,076,442...151,079,014
|
|
G |
Plau |
plasminogen activator, urokinase |
treatment |
IDA |
associated with Endotoxemia |
RGD |
PMID:21473829 PMID:23324284 |
RGD:5147760, RGD:7241552 |
NCBI chr15:3,456,230...3,462,732
Ensembl chr15:3,456,232...3,462,775
|
|
G |
Pparg |
peroxisome proliferator-activated receptor gamma |
|
IEP ISO |
protein:decreased expression:lung (rat) CTD Direct Evidence: therapeutic |
CTD RGD |
PMID:21153920 PMID:16083301 |
RGD:8553030 |
NCBI chr 4:148,423,102...148,548,471
Ensembl chr 4:148,423,194...148,548,468
|
|
G |
Prdm1 |
PR/SET domain 1 |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:33109608 |
|
NCBI chr20:47,959,858...47,981,488
Ensembl chr20:47,959,858...47,981,488
|
|
G |
Prkaa1 |
protein kinase AMP-activated catalytic subunit alpha 1 |
|
ISO |
|
RGD |
PMID:21595935 |
RGD:6484539 |
NCBI chr 2:54,240,298...54,275,978
Ensembl chr 2:54,240,137...54,275,978
|
|
G |
Proc |
protein C, inactivator of coagulation factors Va and VIIIa |
treatment |
ISO |
associated with Pseudomonas Infections associated with Intestinal Reperfusion Injury |
RGD |
PMID:16553944 PMID:18367148 |
RGD:11100043, RGD:11250405 |
NCBI chr18:23,764,367...23,774,816
Ensembl chr18:23,764,368...23,775,133
|
|
G |
Procr |
protein C receptor |
treatment |
IEP |
|
RGD |
PMID:20095324 |
RGD:13515130 |
NCBI chr 3:144,254,596...144,258,863
Ensembl chr 3:144,254,380...144,258,903
|
|
G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
ISO IEP |
protein:increased expression:lung |
RGD |
PMID:20926798 PMID:19567182 |
RGD:5135287, RGD:5135496 |
NCBI chr13:62,164,080...62,169,770
Ensembl chr13:62,163,932...62,172,188
|
|
G |
Scgb1a1 |
secretoglobin family 1A member 1 |
|
IEP ISO |
protein:decreased expression:lung |
RGD |
PMID:18420837 PMID:16226776 |
RGD:5143982, RGD:5144142 |
NCBI chr 1:205,977,060...205,980,610
Ensembl chr 1:205,977,060...205,980,610
|
|
G |
Serpinc1 |
serpin family C member 1 |
treatment |
ISO |
associated with Endotoxemia |
RGD |
PMID:17940748 |
RGD:11035256 |
NCBI chr13:73,257,208...73,271,476
Ensembl chr13:73,257,179...73,284,293
|
|
G |
Serpine1 |
serpin family E member 1 |
treatment |
IDA IEP |
associated with Shock, Hemorrhagic;mRNA:increased expression:lung (rat) associated with Sepsis |
RGD |
PMID:25934465 PMID:10745022 PMID:18182560 |
RGD:11075078, RGD:11080967, RGD:11080962 |
NCBI chr12:19,601,272...19,611,657
Ensembl chr12:19,601,272...19,611,657
|
|
G |
Serping1 |
serpin family G member 1 |
treatment |
ISO |
|
RGD |
PMID:11685347 |
RGD:8661650 |
NCBI chr 3:69,842,726...69,852,583
Ensembl chr 3:69,842,739...69,852,034
|
|
G |
Sftpa1 |
surfactant protein A1 |
|
ISO |
mRNA, protein:increased expression:pneumocyte |
RGD |
PMID:8569184 |
RGD:4143451 |
NCBI chr16:17,008,180...17,011,686
Ensembl chr16:17,008,180...17,011,685
|
|
G |
Sftpb |
surfactant protein B |
treatment |
IEP |
|
RGD |
PMID:22295533 |
RGD:151667443 |
NCBI chr 4:104,359,303...104,368,439
Ensembl chr 4:104,359,396...104,368,436
|
|
G |
Sftpd |
surfactant protein D |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:30060251 |
|
NCBI chr16:17,046,491...17,058,968
Ensembl chr16:17,046,483...17,059,927
|
|
G |
Slpi |
secretory leukocyte peptidase inhibitor |
severity treatment |
IMP IEP |
associated with Endotoxemia |
RGD |
PMID:10092827 PMID:25466948 |
RGD:9999422, RGD:9999425 |
NCBI chr 3:153,082,208...153,084,457
Ensembl chr 3:153,082,369...153,084,453
|
|
G |
Tac1 |
tachykinin, precursor 1 |
|
ISO |
|
RGD |
PMID:19797759 |
RGD:5147812 |
NCBI chr 4:35,679,183...35,687,180
Ensembl chr 4:35,679,704...35,687,178
|
|
G |
Tacr1 |
tachykinin receptor 1 |
|
ISO |
mRNA:increased expression:lung |
RGD |
PMID:18523300 |
RGD:5147819 |
NCBI chr 4:114,920,844...115,089,733
Ensembl chr 4:114,920,844...115,089,733
|
|
G |
Tff1 |
trefoil factor 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19880587 |
|
NCBI chr20:9,235,736...9,239,597
Ensembl chr20:9,235,736...9,239,597
|
|
G |
Tff2 |
trefoil factor 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19880587 |
|
NCBI chr20:9,215,750...9,219,619
Ensembl chr20:9,215,761...9,219,619
|
|
G |
Tgfb1 |
transforming growth factor, beta 1 |
treatment |
ISO |
CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:16100012 PMID:25278421 |
RGD:39939031 |
NCBI chr 1:81,196,532...81,212,848
Ensembl chr 1:81,196,532...81,212,847
|
|
G |
Thbd |
thrombomodulin |
treatment |
ISO IEP |
associated with Endotoxemia |
RGD |
PMID:19342415 PMID:20095324 PMID:19536047 |
RGD:5131887, RGD:13515130, RGD:5685372 |
NCBI chr 3:135,863,366...135,867,018
Ensembl chr 3:135,862,835...135,867,193
|
|
G |
Timp2 |
TIMP metallopeptidase inhibitor 2 |
severity |
IMP |
|
RGD |
PMID:10092827 |
RGD:9999422 |
NCBI chr10:103,541,199...103,590,611
Ensembl chr10:103,531,505...103,590,611
|
|
G |
Tlr4 |
toll-like receptor 4 |
|
IEP |
|
RGD |
PMID:19567182 |
RGD:5135496 |
NCBI chr 5:80,145,867...80,159,501
Ensembl chr 5:80,145,826...80,159,628
|
|
G |
Tnf |
tumor necrosis factor |
treatment no_association |
IEP ISO |
mRNA, protein:increased expression:lung CTD Direct Evidence: marker/mechanism associated with Liver Reperfusion Injury DNA:SNP:promoter:rs1799964 (human) DNA:SNP:promoter:-308G>A (rs1800629) (human) protein:increased expression:respiratory system fluid/secretion |
CTD RGD |
PMID:34390737 PMID:21767135 PMID:11129814 PMID:30412745 PMID:30412745 PMID:19106808 More...
|
RGD:6480432, RGD:14995473, RGD:14975158, RGD:14975158, RGD:5147925 |
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
|
|
G |
Tnfaip6 |
TNF alpha induced protein 6 |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:26313688 |
|
NCBI chr 3:36,502,250...36,521,652
Ensembl chr 3:36,502,188...36,521,649
|
|
G |
Trem1 |
triggering receptor expressed on myeloid cells 1 |
exacerbates ameliorates |
IMP IDA |
|
RGD |
PMID:26832696 PMID:26832696 |
RGD:127284840, RGD:127284840 |
NCBI chr 9:12,763,819...12,779,285
Ensembl chr 9:12,763,819...12,779,203
|
|
G |
Txn1 |
thioredoxin 1 |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:16298680 |
|
NCBI chr 5:72,712,334...72,724,564
Ensembl chr 5:72,711,933...72,724,629
|
|
G |
Usp18 |
ubiquitin specific peptidase 18 |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:33930521 |
|
NCBI chr 4:154,471,634...154,499,154
Ensembl chr 4:154,471,592...154,499,144
|
|
G |
Vegfa |
vascular endothelial growth factor A |
|
IEP |
associated with Endotoxemia;mRNA, protein:altered expression:lung, plasma |
RGD |
PMID:21528367 |
RGD:5684427 |
NCBI chr 9:14,955,300...14,970,641
Ensembl chr 9:14,955,300...14,970,641
|
|
G |
Vip |
vasoactive intestinal peptide |
|
IDA ISO |
associated with Endotoxemia CTD Direct Evidence: therapeutic |
CTD RGD |
PMID:8643465 PMID:20441697 |
RGD:4145303 |
NCBI chr 1:42,064,878...42,073,219
Ensembl chr 1:42,065,120...42,073,216
|
|
G |
Xdh |
xanthine dehydrogenase |
treatment |
IEP |
|
RGD |
PMID:9655743 |
RGD:13209002 |
NCBI chr 6:21,530,463...21,592,172
Ensembl chr 6:21,530,113...21,592,268
|
|
G |
Zc3h12a |
zinc finger CCCH type containing 12A |
severity |
ISO |
associated with toxic shock syndrome |
RGD |
PMID:23422584 |
RGD:39938961 |
NCBI chr 5:137,376,562...137,385,351
Ensembl chr 5:137,376,564...137,385,351
|
|
|
G |
Epo |
erythropoietin |
treatment |
ISO |
|
RGD |
PMID:23415790 |
RGD:10401075 |
NCBI chr12:19,204,258...19,207,948
Ensembl chr12:19,204,508...19,207,946
|
|
G |
F7 |
coagulation factor VII |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:12503044 |
|
NCBI chr16:76,489,779...76,500,636
Ensembl chr16:76,489,717...76,500,610
|
|
|
G |
Cnr2 |
cannabinoid receptor 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:34537380 |
|
NCBI chr 5:148,125,222...148,151,548
Ensembl chr 5:148,125,604...148,151,548
|
|
|
G |
Atp1a4 |
ATPase Na+/K+ transporting subunit alpha 4 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:29394417 |
|
NCBI chr13:84,683,766...84,719,790
Ensembl chr13:84,683,768...84,719,687
|
|
G |
Flacc1 |
flagellum associated containing coiled-coil domains 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:29394417 |
|
NCBI chr 9:60,315,581...60,343,692
Ensembl chr 9:60,315,582...60,343,648
|
|
G |
Il1a |
interleukin 1 alpha |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20005085 |
|
NCBI chr 3:116,526,601...116,537,055
Ensembl chr 3:116,526,604...116,536,822
|
|
G |
Il1b |
interleukin 1 beta |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20005085 |
|
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
|
|
G |
Il1rn |
interleukin 1 receptor antagonist |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20005085 |
|
NCBI chr 3:7,111,567...7,127,451
Ensembl chr 3:7,111,550...7,127,445
|
|
G |
Rbm26 |
RNA binding motif protein 26 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:29394417 |
|
NCBI chr15:81,884,783...81,964,245
Ensembl chr15:81,887,219...81,964,118
|
|
G |
Tnf |
tumor necrosis factor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20005085 |
|
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
|
|
|
G |
Abcb1a |
ATP binding cassette subfamily B member 1A |
susceptibility |
ISO |
DNA:missense mutation:cds:p.G671V (human) |
RGD |
PMID:16330681 |
RGD:11041175 |
NCBI chr 4:25,357,467...25,529,941
Ensembl chr 4:25,158,362...25,442,709
|
|
G |
Capn2 |
calpain 2 |
treatment |
IEP |
|
RGD |
PMID:25634181 |
RGD:13792617 |
NCBI chr13:94,150,244...94,200,969
Ensembl chr13:94,150,240...94,200,969
|
|
G |
Ercc2 |
ERCC excision repair 2, TFIIH core complex helicase subunit |
|
ISO |
associated with Leukemia, Myeloid, Acute;DNA:SNP:exon:p.K751Q (rs13181) (human) |
RGD |
PMID:24284041 |
RGD:11252190 |
NCBI chr 1:79,033,342...79,047,102
Ensembl chr 1:79,033,326...79,047,102
|
|
|
G |
Atp7a |
ATPase copper transporting alpha |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:2346371 PMID:25449986 |
|
NCBI chr X:71,094,144...71,201,550
Ensembl chr X:71,094,202...71,198,354
|
|
G |
Edn2 |
endothelin 2 |
|
ISO |
|
RGD |
PMID:11947982 |
RGD:1580915 |
NCBI chr 5:133,751,316...133,756,814
Ensembl chr 5:133,751,217...133,756,814
|
|
G |
Fbn1 |
fibrillin 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18178469 |
|
NCBI chr 3:112,554,257...112,750,835
Ensembl chr 3:112,554,925...112,750,889
|
|
G |
Mmp2 |
matrix metallopeptidase 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18178469 |
|
NCBI chr19:14,154,657...14,182,870
Ensembl chr19:14,154,657...14,182,870
|
|
G |
Mmp9 |
matrix metallopeptidase 9 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18178469 |
|
NCBI chr 3:153,684,158...153,692,118
Ensembl chr 3:153,683,858...153,692,120
|
|
G |
Npr1 |
natriuretic peptide receptor 1 |
|
ISO |
associated with Hypertension |
RGD |
PMID:9405681 |
RGD:737701 |
NCBI chr 2:175,934,181...175,950,118
Ensembl chr 2:175,934,181...175,949,505
|
|
G |
Vkorc1 |
vitamin K epoxide reductase complex, subunit 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16549638 |
|
NCBI chr 1:182,502,491...182,505,012
Ensembl chr 1:182,500,844...182,505,008
|
|
|
G |
Arg1 |
arginase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:26699812 |
|
NCBI chr 1:20,475,878...20,488,422
Ensembl chr 1:20,475,968...20,488,422
|
|
G |
Atf6 |
activating transcription factor 6 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25324550 |
|
NCBI chr13:82,927,579...83,106,381
Ensembl chr13:82,930,034...83,107,177
|
|
G |
Cfd |
complement factor D |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:22832039 |
|
NCBI chr 7:9,813,148...9,814,871
Ensembl chr 7:9,813,150...9,815,053
|
|
G |
Clca1 |
chloride channel accessory 1 |
|
ISO |
mRNA, protein:increased expression:lung |
RGD |
PMID:17637221 |
RGD:4145655 |
NCBI chr 2:233,938,677...233,964,369
Ensembl chr 2:233,938,677...233,964,369
|
|
G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
|
ISO |
mRNA:decreased expression:leukocyte |
RGD |
PMID:20514434 |
RGD:4892076 |
NCBI chr 1:195,840,330...195,850,728
Ensembl chr 1:195,840,058...195,864,023
|
|
G |
Ddit3 |
DNA-damage inducible transcript 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25324550 |
|
NCBI chr 7:63,115,645...63,121,203
Ensembl chr 7:63,116,380...63,121,201
|
|
G |
Ephx1 |
epoxide hydrolase 1 |
susceptibility |
ISO |
DNA:SNP:exon:p.Y113H (rs1051740) (human) |
RGD |
PMID:17159790 |
RGD:4889408 |
NCBI chr13:92,714,315...92,744,124
Ensembl chr13:92,714,315...92,790,235
|
|
G |
Gstm1 |
glutathione S-transferase mu 1 |
susceptibility |
ISO |
DNA:deletion: : |
RGD |
PMID:9055949 |
RGD:5490588 |
NCBI chr 2:195,649,845...195,655,402
Ensembl chr 2:195,649,845...195,655,411
|
|
G |
Gstt1 |
glutathione S-transferase theta 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17563610 |
|
NCBI chr20:12,856,613...12,873,586
Ensembl chr20:12,856,669...12,873,585
|
|
G |
Hspa5 |
heat shock protein family A (Hsp70) member 5 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25324550 |
|
NCBI chr 3:18,055,507...18,059,969
Ensembl chr 3:18,055,405...18,059,891
|
|
G |
Il1b |
interleukin 1 beta |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:8473757 |
|
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
|
|
G |
Nlrp3 |
NLR family, pyrin domain containing 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:24142982 |
|
NCBI chr10:44,326,770...44,353,814
Ensembl chr10:44,328,566...44,352,811
|
|
G |
Nos2 |
nitric oxide synthase 2 |
|
ISO IEP |
CTD Direct Evidence: marker/mechanism mRNA,protein:increased expression:lung |
CTD RGD |
PMID:12160931 PMID:12160931 PMID:12051993 |
RGD:4891441, RGD:4891438 |
NCBI chr10:63,815,308...63,851,208
Ensembl chr10:63,815,308...63,851,210
|
|
G |
Prdx1 |
peroxiredoxin 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:22537621 |
|
NCBI chr 5:130,147,276...130,162,850
Ensembl chr 5:130,147,204...130,162,856
|
|
G |
Prdx2 |
peroxiredoxin 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:22537621 |
|
NCBI chr19:23,180,927...23,186,217
Ensembl chr19:23,180,930...23,186,194
|
|
G |
Serpina1 |
serpin family A member 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:12368052 |
|
NCBI chr 6:122,866,314...122,888,339
Ensembl chr 6:122,866,312...122,888,339
|
|
G |
Spp1 |
secreted phosphoprotein 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16221779 PMID:21514415 |
|
NCBI chr14:5,308,885...5,315,120
Ensembl chr14:5,308,885...5,315,162
|
|
G |
Tnc |
tenascin C |
|
ISO |
protein:increased expression:pleura |
RGD |
PMID:10950882 |
RGD:4889594 |
NCBI chr 5:77,375,851...77,460,712
Ensembl chr 5:77,375,851...77,460,624
|
|
G |
Tnf |
tumor necrosis factor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:8473757 PMID:20486865 |
|
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
|
|
G |
Tpm4 |
tropomyosin 4 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:22537621 |
|
NCBI chr16:17,684,415...17,698,456
Ensembl chr16:17,683,195...17,705,984
|
|
|
G |
Hif1a |
hypoxia inducible factor 1 subunit alpha |
|
IEP |
mRNA, protein:increased expression:myocardium, lung (rat) |
RGD |
PMID:17285858 |
RGD:9068458 |
NCBI chr 6:92,624,059...92,669,262
Ensembl chr 6:92,624,390...92,669,261
|
|
G |
Ift80 |
intraflagellar transport 80 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17468754 |
|
NCBI chr 2:153,144,707...153,240,024
Ensembl chr 2:153,145,795...153,240,024
|
|
G |
Jun |
Jun proto-oncogene, AP-1 transcription factor subunit |
|
ISO |
|
RGD |
PMID:18620825 |
RGD:4890002 |
NCBI chr 5:109,894,175...109,897,268
Ensembl chr 5:109,893,145...109,897,656
|
|
G |
Sox4 |
SRY-box transcription factor 4 |
|
IDA |
|
RGD |
PMID:12011571 |
RGD:1581119 |
NCBI chr17:35,667,809...35,672,515
Ensembl chr17:35,667,537...35,673,665
|
|
|
G |
Cat |
catalase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17963755 |
|
NCBI chr 3:89,842,393...89,874,577
Ensembl chr 3:89,842,399...89,874,478
|
|
G |
Col1a1 |
collagen type I alpha 1 chain |
|
ISO |
ClinVar Annotator: match by term: Asphyxia neonatorum |
ClinVar |
PMID:8364588 PMID:25741868 |
|
NCBI chr10:79,883,622...79,900,625
Ensembl chr10:79,883,622...79,900,624
|
|
G |
Ercc2 |
ERCC excision repair 2, TFIIH core complex helicase subunit |
|
IEP |
mRNA:increased expression:brain |
RGD |
PMID:9763211 |
RGD:2302855 |
NCBI chr 1:79,033,342...79,047,102
Ensembl chr 1:79,033,326...79,047,102
|
|
G |
Ercc3 |
ERCC excision repair 3, TFIIH core complex helicase subunit |
|
IEP |
mRNA:decreased expression:brain |
RGD |
PMID:9763211 |
RGD:2302855 |
NCBI chr18:23,883,613...23,914,326
Ensembl chr18:23,883,580...23,914,329
|
|
G |
Gstm1 |
glutathione S-transferase mu 1 |
severity |
ISO |
DNA:deletion, haplotype:: (human) |
RGD |
PMID:21058530 |
RGD:12792218 |
NCBI chr 2:195,649,845...195,655,402
Ensembl chr 2:195,649,845...195,655,411
|
|
G |
Htra2 |
HtrA serine peptidase 2 |
treatment |
IEP |
protein:increased expression:kidney: |
RGD |
PMID:20704803 |
RGD:10402931 |
NCBI chr 4:115,556,914...115,560,202
Ensembl chr 4:115,556,916...115,560,095
|
|
G |
Map2 |
microtubule-associated protein 2 |
|
IEP |
|
RGD |
PMID:21858873 |
RGD:6483085 |
NCBI chr 9:67,723,422...67,981,886
Ensembl chr 9:67,723,371...67,979,809
|
|
G |
Pdia3 |
protein disulfide isomerase family A, member 3 |
|
IEP |
protein:increased expression:hippocampus: |
RGD |
PMID:15453273 |
RGD:9999183 |
NCBI chr 3:108,388,189...108,412,013
Ensembl chr 3:108,388,245...108,413,236
|
|
G |
Psen1 |
presenilin 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17963755 |
|
NCBI chr 6:103,323,014...103,375,088
Ensembl chr 6:103,323,120...103,371,650
|
|
G |
Psen2 |
presenilin 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17963755 |
|
NCBI chr13:91,967,506...91,993,240
Ensembl chr13:91,967,983...91,993,174
|
|
G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17963755 |
|
NCBI chr13:62,164,080...62,169,770
Ensembl chr13:62,163,932...62,172,188
|
|
G |
S100b |
S100 calcium binding protein B |
|
ISO |
protein:increased expression:urine |
RGD |
PMID:14707571 |
RGD:5508819 |
NCBI chr20:12,372,866...12,381,619
Ensembl chr20:12,372,881...12,394,743
|
|
G |
Sod1 |
superoxide dismutase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17963755 |
|
NCBI chr11:29,456,673...29,462,249
Ensembl chr11:29,456,558...29,462,249
|
|
G |
Sod2 |
superoxide dismutase 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17963755 |
|
NCBI chr 1:47,638,318...47,645,163
Ensembl chr 1:47,636,528...47,645,189
|
|
G |
Xrcc1 |
X-ray repair cross complementing 1 |
|
IEP |
mRNA:increased expression:brain |
RGD |
PMID:9763211 |
RGD:2302855 |
NCBI chr 1:80,140,495...80,168,705
Ensembl chr 1:80,141,207...80,168,701
|
|
|
G |
Ace |
angiotensin I converting enzyme |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:10194187 |
|
NCBI chr10:90,910,316...90,930,437
Ensembl chr10:90,910,316...90,931,131
|
|
G |
Btnl2 |
butyrophilin-like 2 |
susceptibility |
ISO |
DNA:SNP: :rs3117099(human) CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:17927685 PMID:17927685 |
RGD:9685029 |
NCBI chr20:4,490,904...4,502,557
Ensembl chr20:4,489,517...4,503,341
|
|
G |
Ccr5 |
C-C motif chemokine receptor 5 |
disease_progression |
ISO |
DNA:polymorphisms:5' utr:multiple (human) |
RGD |
PMID:20075058 |
RGD:4892065 |
NCBI chr 8:123,752,423...123,757,538
Ensembl chr 8:123,752,325...123,759,260
|
|
G |
Cd28 |
Cd28 molecule |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:12952926 |
|
NCBI chr 9:62,166,324...62,194,674
Ensembl chr 9:62,166,192...62,194,685
|
|
G |
Gclm |
glutamate cysteine ligase, modifier subunit |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16766924 |
|
NCBI chr 2:210,347,482...210,367,537
Ensembl chr 2:210,347,482...210,367,535
|
|
G |
Hmox1 |
heme oxygenase 1 |
|
ISO |
protein:increased activity:sputum |
RGD |
PMID:19453654 |
RGD:4145349 |
NCBI chr19:13,466,287...13,474,082
Ensembl chr19:13,467,244...13,474,079
|
|
G |
Il2ra |
interleukin 2 receptor subunit alpha |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:8977230 |
|
NCBI chr17:66,849,974...66,898,665
Ensembl chr17:66,849,974...66,898,697
|
|
G |
Il6 |
interleukin 6 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:8428540 |
|
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
|
|
G |
RT1-Db1 |
RT1 class II, locus Db1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16272364 PMID:17927685 |
|
NCBI chr20:4,548,664...4,558,237
Ensembl chr20:4,548,666...4,558,258
|
|
G |
Tgfb1 |
transforming growth factor, beta 1 |
severity |
ISO |
DNA:polymorphisms: :-509C>T (human) CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:15750822 PMID:17785866 PMID:17785866 |
RGD:4145294 |
NCBI chr 1:81,196,532...81,212,848
Ensembl chr 1:81,196,532...81,212,847
|
|
G |
Tnf |
tumor necrosis factor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:8428540 PMID:12449171 PMID:15127972 PMID:16980557 |
|
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
|
|
|
G |
Ccr5 |
C-C motif chemokine receptor 5 |
|
IEP |
mRNA:increased expression:multiple organs (rat) |
RGD |
PMID:18554634 |
RGD:4890426 |
NCBI chr 8:123,752,423...123,757,538
Ensembl chr 8:123,752,325...123,759,260
|
|
|
G |
App |
amyloid beta precursor protein |
|
IEP |
|
RGD |
PMID:24224042 |
RGD:10054251 |
NCBI chr11:24,019,774...24,236,584
Ensembl chr11:24,019,778...24,236,561
|
|
|
G |
Alox5 |
arachidonate 5-lipoxygenase |
|
IMP |
|
RGD |
PMID:19884440 |
RGD:2317529 |
NCBI chr 4:149,531,329...149,578,696
Ensembl chr 4:149,531,515...149,578,743
|
|
G |
Bglap |
bone gamma-carboxyglutamate protein |
|
ISO |
associated with kidney failure, chronic; |
RGD |
PMID:21784896 |
RGD:7207231 |
NCBI chr 2:173,838,518...173,839,495
Ensembl chr 2:173,838,518...173,839,495
|
|
G |
Bmp2 |
bone morphogenetic protein 2 |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:27394662 |
|
NCBI chr 3:120,812,660...120,822,579
Ensembl chr 3:120,812,882...120,821,397
|
|
G |
Bmp7 |
bone morphogenetic protein 7 |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:27394662 |
|
NCBI chr 3:161,639,915...161,716,938
Ensembl chr 3:161,516,462...161,716,788
|
|
G |
Ccdc134 |
coiled-coil domain containing 134 |
|
ISO |
ClinVar Annotator: match by term: Recurrent fractures |
ClinVar |
PMID:25741868 PMID:32181939 PMID:34204301 PMID:35019224 |
|
NCBI chr 7:113,644,557...113,659,050
Ensembl chr 7:113,644,639...113,659,050
|
|
G |
Col1a1 |
collagen type I alpha 1 chain |
|
ISO |
ClinVar Annotator: match by term: Recurrent fractures |
ClinVar RGD |
PMID:25741868 PMID:8432871 |
RGD:734801 |
NCBI chr10:79,883,622...79,900,625
Ensembl chr10:79,883,622...79,900,624
|
|
G |
Dkk1 |
dickkopf WNT signaling pathway inhibitor 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:22504420 |
|
NCBI chr 1:228,381,521...228,385,202
Ensembl chr 1:228,381,521...228,385,202
|
|
G |
Esr1 |
estrogen receptor 1 |
no_association |
ISO |
DNA:SNP:intron:rs9340799 (human) DNA:SNP, repeat:promoter:rs2234693 (human) |
RGD |
PMID:15523071 PMID:15523071 |
RGD:10045827, RGD:10045827 |
NCBI chr 1:41,106,335...41,499,104
Ensembl chr 1:41,210,475...41,495,002
|
|
G |
Fam210a |
family with sequence similarity 210, member A |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:22504420 |
|
NCBI chr18:61,846,447...61,886,123
Ensembl chr18:61,852,907...61,886,171
|
|
G |
Fgf2 |
fibroblast growth factor 2 |
|
ISO |
associated with Diabetes Mellitus, Experimental |
RGD |
PMID:8033826 |
RGD:2315907 |
NCBI chr 2:120,236,328...120,290,673
Ensembl chr 2:120,236,328...120,291,221
|
|
G |
Fkbp10 |
FKBP prolyl isomerase 10 |
|
ISO |
ClinVar Annotator: match by term: Recurrent fractures |
ClinVar |
PMID:20362275 PMID:20839288 PMID:21567934 PMID:22689593 PMID:22949511 PMID:25741868 PMID:26538303 PMID:27509835 PMID:27717089 PMID:27762305 PMID:28492532 More...
|
|
NCBI chr10:85,345,434...85,357,998
Ensembl chr10:85,346,126...85,427,330
|
|
G |
Gdf2 |
growth differentiation factor 2 |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:27394662 |
|
NCBI chr16:9,255,430...9,261,429
Ensembl chr16:9,255,430...9,261,429
|
|
G |
Irx5 |
iroquois homeobox 5 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:22581230 |
|
NCBI chr19:14,639,052...14,643,911
Ensembl chr19:14,624,225...14,642,318
|
|
G |
Lrp5 |
LDL receptor related protein 5 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:22504420 |
|
NCBI chr 1:200,814,247...200,917,581
Ensembl chr 1:200,814,250...200,917,581
|
|
G |
Mepe |
matrix extracellular phosphoglycoprotein |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:22504420 |
|
NCBI chr14:5,420,634...5,432,186
Ensembl chr14:5,420,635...5,432,183
|
|
G |
Pecam1 |
platelet and endothelial cell adhesion molecule 1 |
|
ISO |
|
RGD |
PMID:21788831 |
RGD:6771211 |
NCBI chr10:91,590,521...91,652,279
Ensembl chr10:91,590,521...91,652,116
|
|
G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
IMP |
|
RGD |
PMID:18795192 |
RGD:5135218 |
NCBI chr13:62,164,080...62,169,770
Ensembl chr13:62,163,932...62,172,188
|
|
G |
Pth |
parathyroid hormone |
|
ISO |
associated with Renal Insufficiency, Chronic; protein:increased expression:serum (human) CTD Direct Evidence: therapeutic |
CTD RGD |
PMID:16094769 PMID:23043229 |
RGD:7242731 |
NCBI chr 1:167,508,121...167,511,530
Ensembl chr 1:167,508,598...167,511,530
|
|
G |
Runx1 |
RUNX family transcription factor 1 |
|
IEP |
|
RGD |
PMID:21252473 |
RGD:11252151 |
NCBI chr11:31,839,880...32,074,427
Ensembl chr11:31,843,764...32,074,542
|
|
G |
Runx2 |
RUNX family transcription factor 2 |
|
IEP |
|
RGD |
PMID:21252473 |
RGD:11252151 |
NCBI chr 9:16,167,504...16,492,826
Ensembl chr 9:16,167,482...16,492,167
|
|
G |
Slc25a13 |
solute carrier family 25 member 13 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:22504420 |
|
NCBI chr 4:34,179,224...34,361,912
Ensembl chr 4:34,179,224...34,361,902
|
|
G |
Smad6 |
SMAD family member 6 |
|
IEP |
|
RGD |
PMID:11920662 |
RGD:724455 |
NCBI chr 8:64,450,114...64,519,673
Ensembl chr 8:64,450,114...64,519,763
|
|
G |
Sox9 |
SRY-box transcription factor 9 |
|
IEP |
|
RGD |
PMID:21252473 |
RGD:11252151 |
NCBI chr10:97,806,485...97,811,994
Ensembl chr10:97,806,485...97,811,994
|
|
G |
Sptbn1 |
spectrin, beta, non-erythrocytic 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:22504420 |
|
NCBI chr14:103,842,684...104,008,507
Ensembl chr14:103,842,684...104,008,507
|
|
G |
Tgfbr2 |
transforming growth factor, beta receptor 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20358619 |
|
NCBI chr 8:115,794,537...115,883,615
Ensembl chr 8:115,794,537...115,883,228
|
|
G |
Tnfrsf1b |
TNF receptor superfamily member 1B |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15071724 |
|
NCBI chr 5:157,070,642...157,104,216
Ensembl chr 5:157,070,642...157,104,206
|
|
|
G |
Cfl1 |
cofilin 1 |
treatment |
ISO |
|
RGD |
PMID:25708984 |
RGD:12738361 |
NCBI chr 1:202,796,012...202,801,337
Ensembl chr 1:202,786,627...202,817,587
|
|
|
G |
Drd2 |
dopamine receptor D2 |
|
IEP |
|
RGD |
PMID:26448536 |
RGD:13506960 |
NCBI chr 8:49,708,903...49,772,888
Ensembl chr 8:49,708,927...49,772,875
|
|
G |
Drd3 |
dopamine receptor D3 |
|
IEP |
|
RGD |
PMID:26448536 |
RGD:13506960 |
NCBI chr11:56,879,689...56,931,901
Ensembl chr11:56,879,689...56,940,596
|
|
G |
Drd4 |
dopamine receptor D4 |
|
IEP |
|
RGD |
PMID:26448536 |
RGD:13506960 |
NCBI chr 1:196,396,366...196,400,824
Ensembl chr 1:196,396,366...196,399,553
|
|
G |
Il6 |
interleukin 6 |
treatment |
IDA |
|
RGD |
PMID:27113205 |
RGD:11062140 |
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
|
|
|
G |
Casp3 |
caspase 3 |
treatment |
IEP |
|
RGD |
PMID:28140659 |
RGD:13782305 |
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
|
|
G |
Casp8 |
caspase 8 |
treatment |
IEP |
|
RGD |
PMID:28140659 |
RGD:13782305 |
NCBI chr 9:60,263,863...60,312,542
Ensembl chr 9:60,264,075...60,312,542
|
|
|
G |
Abcc8 |
ATP binding cassette subfamily C member 8 |
treatment |
IMP |
|
RGD |
PMID:21107131 |
RGD:12791995 |
NCBI chr 1:96,598,663...96,679,495
Ensembl chr 1:96,598,647...96,679,510
|
|
G |
Acan |
aggrecan |
|
IEP |
mRNA:increased expression:fascia dentata (rat) |
RGD |
PMID:18511192 |
RGD:2315807 |
NCBI chr 1:132,981,034...133,044,416
Ensembl chr 1:132,981,582...133,043,627
|
|
G |
Actr2 |
actin related protein 2 |
|
IEP |
mRNA, protein:decreased expression:hippocampus (rat) |
RGD |
PMID:22120305 |
RGD:11530046 |
NCBI chr14:94,296,443...94,333,735
Ensembl chr14:94,296,443...94,340,524
|
|
G |
Adcyap1 |
adenylate cyclase activating polypeptide 1 |
|
IDA |
|
RGD |
PMID:16689670 |
RGD:2325298 |
NCBI chr 9:113,102,632...113,122,500
Ensembl chr 9:113,103,718...113,109,773
|
|
G |
Adra1a |
adrenoceptor alpha 1A |
|
IEP |
mRNA:increased expression:frontal cortex |
RGD |
PMID:20974230 |
RGD:5688366 |
NCBI chr15:40,830,125...40,935,902
Ensembl chr15:40,832,534...40,927,500
|
|
G |
Ager |
advanced glycosylation end product-specific receptor |
|
ISO IEP |
protein:increased expression:brain (rat) |
RGD |
PMID:22915134 PMID:24859607 PMID:22491548 |
RGD:7245513, RGD:8696001, RGD:7245557 |
NCBI chr20:4,148,150...4,151,361
Ensembl chr20:4,147,890...4,151,078
|
|
G |
Aif1 |
allograft inflammatory factor 1 |
|
IEP |
protein:increased expression:cerebral cortex (rat) |
RGD |
PMID:19520144 |
RGD:2313020 |
NCBI chr20:3,646,784...3,652,670
Ensembl chr20:3,646,777...3,652,668
|
|
G |
Aifm1 |
apoptosis inducing factor, mitochondria associated 1 |
|
IEP |
protein:increased expression:nucleus: |
RGD |
PMID:12091479 |
RGD:10053567 |
NCBI chr X:127,650,223...127,689,356
Ensembl chr X:127,650,226...127,689,256
|
|
G |
Akt1 |
AKT serine/threonine kinase 1 |
|
IEP |
protein:increased phosphorylation:brain, neuron |
RGD |
PMID:16234845 |
RGD:5509090 |
NCBI chr 6:131,713,716...131,735,319
Ensembl chr 6:131,713,720...131,733,921
|
|
G |
Alb |
albumin |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:7909931 PMID:17188501 |
|
NCBI chr14:17,607,397...17,622,814
Ensembl chr14:17,607,381...17,622,836
|
|
G |
Ambp |
alpha-1-microglobulin/bikunin precursor |
|
ISO |
protein:increased expression:urine |
RGD |
PMID:14592616 |
RGD:6904155 |
NCBI chr 5:76,568,094...76,578,416
Ensembl chr 5:76,568,094...76,578,331
|
|
G |
Ank3 |
ankyrin 3 |
|
IEP |
|
RGD |
PMID:20557305 |
RGD:6767288 |
NCBI chr20:18,602,267...19,225,831
Ensembl chr20:18,602,786...19,086,300
|
|
G |
Anp32a |
acidic nuclear phosphoprotein 32 family member A |
|
IEP |
|
RGD |
PMID:24385964 |
RGD:10401136 |
Ensembl chr 8:62,827,456...62,865,443
|
|
G |
Apaf1 |
apoptotic peptidase activating factor 1 |
|
IEP |
protein:increased expression:cerebral cortex |
RGD |
PMID:11567033 |
RGD:2325751 |
NCBI chr 7:25,494,143...25,579,540
Ensembl chr 7:25,494,609...25,579,540
|
|
G |
Apbb1 |
amyloid beta precursor protein binding family B member 1 |
|
IEP |
mRNA:increased expression:brain |
RGD |
PMID:12707777 |
RGD:2301208 |
NCBI chr 1:159,896,889...159,920,505
Ensembl chr 1:159,896,880...159,920,627
|
|
G |
Apex1 |
apurinic/apyrimidinic endodeoxyribonuclease 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:11447995 |
|
NCBI chr15:24,144,595...24,146,785
Ensembl chr15:24,144,362...24,146,785
|
|
G |
Apod |
apolipoprotein D |
|
IEP |
mRNA, protein:increased expression:cerebral cortex, glia cell, neuron |
RGD |
PMID:10501208 |
RGD:2311202 |
NCBI chr11:69,431,261...69,452,306
Ensembl chr11:69,431,260...69,452,305
|
|
G |
Apoe |
apolipoprotein E |
|
ISO |
|
GAD |
PMID:15118671 |
RGD:1331525 |
NCBI chr 1:79,353,924...79,357,852
Ensembl chr 1:79,353,916...79,357,932
|
|
G |
App |
amyloid beta precursor protein |
|
ISO |
protein:increased expression:hippocampus |
RGD |
PMID:16300758 |
RGD:10054281 |
NCBI chr11:24,019,774...24,236,584
Ensembl chr11:24,019,778...24,236,561
|
|
G |
Aqp4 |
aquaporin 4 |
|
IEP ISO |
protein:increased expression:cerebral cortex |
RGD |
PMID:21083433 PMID:21488209 |
RGD:5148014, RGD:5148034 |
NCBI chr18:6,507,903...6,524,558
Ensembl chr18:6,507,903...6,524,856
|
|
G |
Asic1 |
acid sensing ion channel subunit 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21307247 |
|
NCBI chr 7:130,798,317...130,828,535
Ensembl chr 7:130,799,917...130,828,541
|
|
G |
Astn1 |
astrotactin 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:14499481 |
|
NCBI chr13:70,537,423...70,855,440
Ensembl chr13:70,537,703...70,855,440
|
|
G |
Atg12 |
autophagy related 12 |
|
IEP |
protein:altered localization:brain |
RGD |
PMID:18059433 |
RGD:2301217 |
NCBI chr18:39,452,247...39,462,424
Ensembl chr18:39,452,191...39,462,418
|
|
G |
Atp5pd |
ATP synthase peripheral stalk subunit d |
treatment |
IDA |
|
RGD |
PMID:26813465 |
RGD:13800884 |
NCBI chr10:100,657,700...100,662,960
Ensembl chr10:100,657,708...100,663,479
|
|
G |
Avpr1a |
arginine vasopressin receptor 1A |
|
IEP |
mRNA:increased expression:cerebral cortex |
RGD |
PMID:17244947 |
RGD:2300372 |
NCBI chr 7:58,114,306...58,118,230
Ensembl chr 7:58,114,284...58,122,215
|
|
G |
Bad |
BCL2-associated agonist of cell death |
|
IEP |
mRNA, protein:increased expression:cerebral cortex |
RGD |
PMID:15941375 |
RGD:2292694 |
NCBI chr 1:204,133,502...204,142,829
Ensembl chr 1:204,131,501...204,142,823
|
|
G |
Bax |
BCL2 associated X, apoptosis regulator |
treatment |
IEP |
|
RGD |
PMID:20888848 |
RGD:10054247 |
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
|
|
G |
Bcat1 |
branched chain amino acid transaminase 1 |
|
IEP |
Protein:increased expression:neurons |
RGD |
PMID:10686349 |
RGD:631308 |
NCBI chr 4:177,964,834...178,046,573
Ensembl chr 4:177,964,834...178,046,597
|
|
G |
Bcl2 |
BCL2, apoptosis regulator |
treatment |
IMP IEP |
|
RGD |
PMID:18093155 PMID:20888848 |
RGD:2293059, RGD:10054247 |
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
|
|
G |
Bdnf |
brain-derived neurotrophic factor |
|
IEP ISO |
CTD Direct Evidence: marker/mechanism|therapeutic |
CTD RGD |
PMID:15500971 PMID:21269288 PMID:20544832 |
RGD:4891136 |
NCBI chr 3:96,165,042...96,215,621
Ensembl chr 3:96,165,042...96,215,615
|
|
G |
Becn1 |
beclin 1 |
|
IEP ISO |
protein:increased expression:neuron, astrocyte CTD Direct Evidence: therapeutic protein:increased expression:hippocampus protein:increased expression:brain |
CTD RGD |
PMID:34929507 PMID:18500386 PMID:24221859 PMID:16874043 |
RGD:6483098, RGD:11558018, RGD:6483314 |
NCBI chr10:86,231,387...86,246,742
Ensembl chr10:86,231,388...86,246,742
|
|
G |
Birc5 |
baculoviral IAP repeat-containing 5 |
|
IEP |
mRNA, protein:increased expression:brain, astrocyte, neuron |
RGD |
PMID:15453988 |
RGD:2293136 |
NCBI chr10:103,072,530...103,081,382
Ensembl chr10:103,073,408...103,081,380
|
|
G |
Bmp6 |
bone morphogenetic protein 6 |
|
IEP |
protein:increased expression:brain, astrocyte, neuron |
RGD |
PMID:16388909 |
RGD:2289020 |
NCBI chr17:26,318,121...26,469,034
Ensembl chr17:26,318,569...26,470,365
|
|
G |
Bmpr2 |
bone morphogenetic protein receptor type 2 |
|
IEP |
mRNA:increased expression:dentate gyrus, neuron |
RGD |
PMID:9080432 |
RGD:5129488 |
NCBI chr 9:61,192,718...61,307,280
Ensembl chr 9:61,190,566...61,301,809
|
|
G |
Bysl |
bystin-like |
|
IEP |
mRNA, protein:increased expression:substantia nigra, striatum (rat) |
RGD |
PMID:15305856 |
RGD:2316201 |
NCBI chr 9:13,382,806...13,392,557
Ensembl chr 9:13,382,557...13,394,339
|
|
G |
C1qa |
complement C1q A chain |
|
IEP |
|
RGD |
PMID:23808389 |
RGD:10054313 |
NCBI chr 5:149,133,635...149,136,482
Ensembl chr 5:149,133,636...149,136,534
|
|
G |
C3 |
complement C3 |
|
IEP |
|
RGD |
PMID:23808389 |
RGD:10054313 |
NCBI chr 9:2,087,437...2,114,366
Ensembl chr 9:2,087,437...2,114,429
|
|
G |
Cask |
calcium/calmodulin dependent serine protein kinase |
|
IEP |
|
RGD |
PMID:25089700 |
RGD:11576302 |
NCBI chr X:8,899,500...9,243,014
Ensembl chr X:8,899,833...9,238,694
|
|
G |
Casp1 |
caspase 1 |
|
IEP |
mRNA, protein:increased expression:brain |
RGD |
PMID:17188500 |
RGD:2315917 |
NCBI chr 8:2,587,812...2,597,403
Ensembl chr 8:2,587,831...2,597,383
|
|
G |
Casp12 |
caspase 12 |
severity |
IEP |
mRNA, protein:increased expression, increased activity:cerebral cortex, hippocampus, neuron, astrocyte |
RGD |
PMID:14675152 |
RGD:2311485 |
NCBI chr 8:2,642,296...2,669,549
Ensembl chr 8:2,642,434...2,674,037
|
|
G |
Casp3 |
caspase 3 |
treatment |
IEP |
|
RGD |
PMID:20888848 |
RGD:10054247 |
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
|
|
G |
Casp8 |
caspase 8 |
|
IEP |
protein:altered localization |
RGD |
PMID:15590916 |
RGD:1624191 |
NCBI chr 9:60,263,863...60,312,542
Ensembl chr 9:60,264,075...60,312,542
|
|
G |
Cast |
calpastatin |
severity |
IEP |
mRNA:increased expression:cerebral cortex |
RGD |
PMID:15307896 |
RGD:5509821 |
NCBI chr 2:3,973,112...4,082,658
Ensembl chr 2:3,973,112...4,082,659
|
|
G |
Ccl2 |
C-C motif chemokine ligand 2 |
treatment |
IEP ISO IMP |
protein:increased expression:brain, neuron CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:21549006 PMID:19210118 PMID:11113322 |
RGD:2306999, RGD:9587789 |
NCBI chr10:67,005,424...67,007,222
Ensembl chr10:67,005,424...67,007,226
|
|
G |
Ccl20 |
C-C motif chemokine ligand 20 |
treatment |
IEP |
|
RGD |
PMID:22040257 |
RGD:7483630 |
NCBI chr 9:84,389,031...84,391,629
Ensembl chr 9:84,388,904...84,391,629
|
|
G |
Ccr5 |
C-C motif chemokine receptor 5 |
|
IEP |
mRNA:increased expression:hippocampus |
RGD |
PMID:24344922 |
RGD:8552265 |
NCBI chr 8:123,752,423...123,757,538
Ensembl chr 8:123,752,325...123,759,260
|
|
G |
Cd14 |
CD14 molecule |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21549006 |
|
NCBI chr18:28,335,522...28,337,383
Ensembl chr18:28,335,340...28,337,261
|
|
G |
Cd40 |
CD40 molecule |
treatment |
IDA |
|
RGD |
PMID:23924471 |
RGD:7248749 |
NCBI chr 3:153,790,372...153,805,279
Ensembl chr 3:153,790,449...153,805,534
|
|
G |
Cd40lg |
CD40 ligand |
treatment |
IEP IDA |
|
RGD |
PMID:11755016 PMID:25972624 |
RGD:8547803, RGD:11344972 |
NCBI chr X:135,127,119...135,138,302
Ensembl chr X:135,126,969...135,138,306
|
|
G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
|
IEP |
protein:increased expression:nucleus: |
RGD |
PMID:9914434 |
RGD:8662346 |
NCBI chr20:7,149,177...7,159,727
Ensembl chr20:7,149,217...7,159,585
|
|
G |
Cdkn1b |
cyclin-dependent kinase inhibitor 1B |
|
IEP |
protein:decreased expression:cerebral cortex |
RGD |
PMID:21728064 |
RGD:10045359 |
NCBI chr 4:167,760,067...167,765,177
Ensembl chr 4:167,760,181...167,764,982
|
|
G |
Cebpa |
CCAAT/enhancer binding protein alpha |
|
ISO |
mRNA, protein:increased expression:cerebral cortex (mouse) |
RGD |
PMID:19833158 |
RGD:10401206 |
NCBI chr 1:87,759,631...87,762,303
Ensembl chr 1:87,759,433...87,762,412
|
|
G |
Cebpb |
CCAAT/enhancer binding protein beta |
|
ISO |
mRNA, protein:increased expression:cerebral cortex (mouse) CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:21549006 PMID:19833158 |
RGD:10401206 |
NCBI chr 3:156,398,035...156,399,466
Ensembl chr 3:156,397,052...156,399,473
|
|
G |
Ces1d |
carboxylesterase 1D |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23159883 |
|
NCBI chr19:13,873,490...13,912,035
Ensembl chr19:13,796,623...13,912,035
|
|
G |
Cfb |
complement factor B |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17474994 |
|
NCBI chr20:3,970,643...3,976,510
Ensembl chr20:3,951,474...3,976,505
|
|
G |
Chrm2 |
cholinergic receptor, muscarinic 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23159883 |
|
NCBI chr 4:65,015,408...65,149,104
Ensembl chr 4:65,014,144...65,149,103
|
|
G |
Chrna7 |
cholinergic receptor nicotinic alpha 7 subunit |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23159883 |
|
NCBI chr 1:116,715,286...116,837,223
Ensembl chr 1:116,714,711...116,837,240
|
|
G |
Ckmt1 |
creatine kinase, mitochondrial 1 |
treatment |
IEP |
|
RGD |
PMID:24252176 |
RGD:11565089 |
NCBI chr 3:108,329,859...108,335,760
Ensembl chr 3:108,330,705...108,335,758
|
|
G |
Clec4e |
C-type lectin domain family 4, member E |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21549006 |
|
NCBI chr 4:156,606,927...156,612,911
Ensembl chr 4:156,607,614...156,612,767
|
|
G |
Cnp |
2',3'-cyclic nucleotide 3' phosphodiesterase |
|
IEP |
protein:increased expression:hippocampus |
RGD |
PMID:20215974 |
RGD:6483336 |
NCBI chr10:85,511,164...85,517,723
Ensembl chr10:85,511,160...85,517,720
|
|
G |
Comt |
catechol-O-methyltransferase |
|
IEP |
protein:increased expression:hippocampus |
RGD |
PMID:17240060 |
RGD:2289740 |
NCBI chr11:82,568,052...82,587,642
Ensembl chr11:82,568,025...82,587,642
|
|
G |
Crp |
C-reactive protein |
disease_progression |
ISO |
|
RGD |
PMID:24456846 |
RGD:9585646 |
NCBI chr13:85,131,635...85,175,179
Ensembl chr13:85,124,977...85,175,178
|
|
G |
Csf2 |
colony stimulating factor 2 |
disease_progression |
IDA |
|
RGD |
PMID:21515263 |
RGD:5686795 |
NCBI chr10:38,386,945...38,388,926
Ensembl chr10:38,386,945...38,389,199
|
|
G |
Csf3 |
colony stimulating factor 3 |
treatment |
ISO |
CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:21549006 PMID:24239694 |
RGD:11039431 |
NCBI chr10:83,660,787...83,664,569
Ensembl chr10:83,661,207...83,663,603
|
|
G |
Cspg4 |
chondroitin sulfate proteoglycan 4 |
|
IEP |
protein:altered expression:cerebral cortex |
RGD |
PMID:19473238 |
RGD:5686860 |
NCBI chr 8:57,264,962...57,300,010
Ensembl chr 8:57,264,962...57,300,010
|
|
G |
Cul5 |
cullin 5 |
|
IEP |
mRNA, protein:decreased expression:cerebral cortex, hippocampus |
RGD |
PMID:17010517 |
RGD:2301432 |
NCBI chr 8:54,012,963...54,066,751
Ensembl chr 8:54,016,006...54,066,666
|
|
G |
Cxcl1 |
C-X-C motif chemokine ligand 1 |
|
IEP |
mRNA:increased expression:choroid plexus, cerebral cortex |
RGD |
PMID:19471279 |
RGD:5135009 |
NCBI chr14:17,193,364...17,195,143
Ensembl chr14:17,193,365...17,195,215
|
|
G |
Cxcl10 |
C-X-C motif chemokine ligand 10 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21549006 |
|
NCBI chr14:15,704,772...15,706,969
Ensembl chr14:15,704,758...15,706,975
|
|
G |
Cxcl2 |
C-X-C motif chemokine ligand 2 |
|
IEP |
protein:increased expression:brain, neuron |
RGD |
PMID:19210118 |
RGD:2306999 |
NCBI chr14:17,181,030...17,183,075
Ensembl chr14:17,181,062...17,183,075
|
|
G |
Cyp11a1 |
cytochrome P450, family 11, subfamily a, polypeptide 1 |
|
IEP |
mRNA:increased expression:hindbrain |
RGD |
PMID:16329132 |
RGD:1599699 |
NCBI chr 8:58,422,807...58,434,342
Ensembl chr 8:58,404,669...58,434,338
|
|
G |
Cyp4f1 |
cytochrome P450, family 4, subfamily f, polypeptide 1 |
|
IEP |
|
RGD |
PMID:18847377 |
RGD:2301705 |
NCBI chr 7:12,010,850...12,022,497
Ensembl chr 7:12,010,852...12,022,046
|
|
G |
Dab2 |
DAB adaptor protein 2 |
|
IEP |
|
RGD |
PMID:15774263 |
RGD:7243841 |
NCBI chr 2:55,514,692...55,567,476
Ensembl chr 2:55,514,700...55,567,476
|
|
G |
Dnmt1 |
DNA methyltransferase 1 |
|
IEP |
|
RGD |
PMID:19429151 |
RGD:9588608 |
NCBI chr 8:19,440,611...19,486,659
Ensembl chr 8:19,440,611...19,486,659
|
|
G |
Dpysl2 |
dihydropyrimidinase-like 2 |
|
IEP |
protein:increased degradation:cerebral cortex, hippocampus |
RGD |
PMID:17402852 |
RGD:2303056 |
NCBI chr15:41,005,551...41,111,724
Ensembl chr15:41,005,551...41,111,829
|
|
G |
Drd2 |
dopamine receptor D2 |
|
IDA |
|
RGD |
PMID:18509630 |
RGD:2311580 |
NCBI chr 8:49,708,903...49,772,888
Ensembl chr 8:49,708,927...49,772,875
|
|
G |
Dusp5 |
dual specificity phosphatase 5 |
|
IEP |
mRNA:increased expression:cerebral cortex |
RGD |
PMID:12503083 |
RGD:2317873 |
NCBI chr 1:252,538,408...252,555,320
Ensembl chr 1:252,538,449...252,551,818
|
|
G |
Eif2s1 |
eukaryotic translation initiation factor 2 subunit alpha |
|
IDA |
|
RGD |
PMID:11526986 |
RGD:10395358 |
NCBI chr 6:97,672,829...97,697,499
Ensembl chr 6:97,672,766...97,706,225
|
|
G |
Eif3e |
eukaryotic translation initiation factor 3 subunit E |
treatment |
IMP |
|
RGD |
PMID:22960363 |
RGD:10395371 |
NCBI chr 7:74,339,848...74,372,483
Ensembl chr 7:74,339,828...74,373,096
|
|
G |
Elk1 |
ETS transcription factor ELK1 |
|
IDA |
|
RGD |
PMID:15362724 |
RGD:7488910 |
NCBI chr X:1,138,826...1,155,713
Ensembl chr X:1,139,756...1,155,713
|
|
G |
Epas1 |
endothelial PAS domain protein 1 |
treatment |
IDA |
|
RGD |
PMID:22960363 |
RGD:10395371 |
NCBI chr 6:7,790,236...7,871,246
Ensembl chr 6:7,790,647...7,871,228
|
|
G |
Epha4 |
Eph receptor A4 |
|
ISO |
protein:increased expression, increased activity:astrocyte |
RGD |
PMID:22318127 |
RGD:5688763 |
NCBI chr 9:78,815,460...78,958,139
Ensembl chr 9:78,815,460...78,958,139
|
|
G |
Ephx2 |
epoxide hydrolase 2 |
|
ISO |
|
RGD |
PMID:21075124 |
RGD:5688356 |
NCBI chr15:40,289,901...40,327,632
Ensembl chr15:40,289,902...40,327,615
|
|
G |
Epo |
erythropoietin |
treatment |
ISO IEP |
CTD Direct Evidence: therapeutic mRNA:increased expression:brain: |
CTD RGD |
PMID:20833152 PMID:23063952 PMID:18093155 |
RGD:10401061, RGD:2293059 |
NCBI chr12:19,204,258...19,207,948
Ensembl chr12:19,204,508...19,207,946
|
|
G |
Epor |
erythropoietin receptor |
|
IEP |
mRNA:increased expression:brain: |
RGD |
PMID:18093155 |
RGD:2293059 |
NCBI chr 8:20,489,678...20,494,257
Ensembl chr 8:20,489,678...20,494,257
|
|
G |
F2 |
coagulation factor II |
severity |
ISO |
|
RGD |
PMID:21355766 |
RGD:5147766 |
NCBI chr 3:77,596,196...77,609,486
Ensembl chr 3:77,596,198...77,609,486
|
|
G |
Fas |
Fas cell surface death receptor |
|
IEP ISO |
mRNA:increased expression:hippocampus associated with Hyperoxia |
RGD |
PMID:16078565 PMID:19107989 |
RGD:1600354, RGD:8662854 |
NCBI chr 1:231,798,963...231,832,591
Ensembl chr 1:231,798,960...231,832,591
|
|
G |
Fgf2 |
fibroblast growth factor 2 |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:21269288 |
|
NCBI chr 2:120,236,328...120,290,673
Ensembl chr 2:120,236,328...120,291,221
|
|
G |
Fmr1 |
fragile X messenger ribonucleoprotein 1 |
|
IEP |
protein:altered localization:hippocampus (rat) |
RGD |
PMID:16510718 |
RGD:11667962 |
NCBI chr X:147,240,239...147,278,057
Ensembl chr X:147,240,301...147,278,050
|
|
G |
Fos |
Fos proto-oncogene, AP-1 transcription factor subunit |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:9630518 |
|
NCBI chr 6:105,121,170...105,124,036
Ensembl chr 6:105,121,170...105,124,036
|
|
G |
Foxp1 |
forkhead box P1 |
treatment |
IDA |
|
RGD |
PMID:26842647 |
RGD:11561903 |
NCBI chr 4:131,559,599...132,155,092
Ensembl chr 4:131,564,756...132,112,258
|
|
G |
G6pd |
glucose-6-phosphate dehydrogenase |
|
IEP |
protein:decreased expression:hippocampus |
RGD |
PMID:18501200 |
RGD:2307353 |
NCBI chr X:152,201,081...152,220,863
Ensembl chr X:152,201,098...152,220,801
|
|
G |
Gabrb3 |
gamma-aminobutyric acid type A receptor subunit beta 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23159883 |
|
NCBI chr 1:108,467,047...108,702,522
Ensembl chr 1:108,296,124...108,698,961
|
|
G |
Gabrg3 |
gamma-aminobutyric acid type A receptor subunit gamma 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23159883 |
|
NCBI chr 1:107,627,450...108,247,483
Ensembl chr 1:107,627,390...108,246,763
|
|
G |
Gdnf |
glial cell derived neurotrophic factor |
|
IEP |
mRNA:increased expression:brain |
RGD |
PMID:18501516 |
RGD:2324932 |
NCBI chr 2:56,893,992...56,919,935
Ensembl chr 2:56,895,010...56,917,209
|
|
G |
Gja1 |
gap junction protein, alpha 1 |
treatment |
IEP |
|
RGD |
PMID:23485053 |
RGD:8662424 |
NCBI chr20:35,756,007...35,768,481
Ensembl chr20:35,755,991...35,768,582
|
|
G |
Gja5 |
gap junction protein, alpha 5 |
|
IEP |
protein:increased expression:cerebral artery |
RGD |
PMID:21895483 |
RGD:7207391 |
NCBI chr 2:184,602,407...184,621,952
Ensembl chr 2:184,564,475...184,621,952
|
|
G |
Gpx1 |
glutathione peroxidase 1 |
|
IEP |
mRNA:decreased expression:hippocampus, neuron |
RGD |
PMID:15791111 |
RGD:2306624 |
NCBI chr 8:109,026,905...109,028,031
Ensembl chr 8:109,026,905...109,028,024
|
|
G |
Grm8 |
glutamate metabotropic receptor 8 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23159883 |
|
NCBI chr 4:55,805,762...56,731,690
Ensembl chr 4:55,805,955...56,730,831
|
|
G |
Gsk3b |
glycogen synthase kinase 3 beta |
|
IEP ISO |
CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:24675465 PMID:22643085 |
RGD:10045646 |
NCBI chr11:62,498,997...62,648,665
Ensembl chr11:62,504,316...62,648,646
|
|
G |
Gsn |
gelsolin |
|
IEP |
|
RGD |
PMID:14588109 |
RGD:1599864 |
NCBI chr 3:18,585,166...18,638,404
Ensembl chr 3:18,585,172...18,638,402
|
|
G |
Hcn1 |
hyperpolarization-activated cyclic nucleotide-gated potassium channel 1 |
|
IEP |
mRNA,protein:decreased expression:hippocampus: |
RGD |
PMID:11726545 |
RGD:9686434 |
NCBI chr 2:49,495,771...49,899,702
Ensembl chr 2:49,495,771...49,899,774
|
|
G |
Hmgb1 |
high mobility group box 1 |
treatment |
IMP |
|
RGD |
PMID:22915134 |
RGD:7245513 |
NCBI chr12:5,973,062...5,978,565
Ensembl chr12:5,901,586...5,978,565
|
|
G |
Hmgcr |
3-hydroxy-3-methylglutaryl-CoA reductase |
|
IMP |
|
RGD |
PMID:18562561 |
RGD:5508455 |
NCBI chr 2:27,997,523...28,018,983
Ensembl chr 2:27,997,525...28,019,703
|
|
G |
Hmox1 |
heme oxygenase 1 |
|
IEP |
|
RGD |
PMID:23470432 |
RGD:10755702 |
NCBI chr19:13,466,287...13,474,082
Ensembl chr19:13,467,244...13,474,079
|
|
G |
Hp |
haptoglobin |
|
IEP |
mRNA:increased expression:liver |
RGD |
PMID:23172820 |
RGD:11041806 |
NCBI chr19:37,539,626...37,544,178
Ensembl chr19:37,539,627...37,544,523
|
|
G |
Hspa1b |
heat shock protein family A (Hsp70) member 1B |
|
ISO |
mRNA:increased expression:brain CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:21549006 PMID:21549006 |
RGD:5147593 |
NCBI chr20:3,870,765...3,873,221
|
|
G |
Hspa4 |
heat shock protein family A (Hsp70) member 4 |
|
IEP |
protein:increased expression:cerebral white matter (rat) |
RGD |
PMID:22067617 |
RGD:5688785 |
NCBI chr10:37,408,025...37,449,080
Ensembl chr10:37,408,025...37,449,001
|
|
G |
Hspb1 |
heat shock protein family B (small) member 1 |
|
IEP |
|
RGD |
PMID:11746764 |
RGD:6480530 |
NCBI chr12:20,794,014...20,795,675
Ensembl chr12:20,794,028...20,795,743
|
|
G |
Htr7 |
5-hydroxytryptamine receptor 7 |
|
IMP |
|
RGD |
PMID:22465320 |
RGD:6482178 |
NCBI chr 1:233,636,442...233,761,063
Ensembl chr 1:233,636,452...233,760,626
|
|
G |
Icam1 |
intercellular adhesion molecule 1 |
|
IEP |
protein:increased expression:brain: |
RGD |
PMID:16230799 |
RGD:11522716 |
NCBI chr 8:19,553,063...19,565,438
Ensembl chr 8:19,553,645...19,565,438
|
|
G |
Ifnl3 |
interferon, lambda 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23159883 |
|
NCBI chr 1:83,814,456...83,816,096
Ensembl chr 1:83,814,564...83,816,096
|
|
G |
Igf1 |
insulin-like growth factor 1 |
treatment |
ISO |
human protein in a rat model |
RGD |
PMID:9344566 |
RGD:12904928 |
NCBI chr 7:22,282,895...22,361,972
Ensembl chr 7:22,282,930...22,359,296
|
|
G |
Igf2 |
insulin-like growth factor 2 |
|
IEP |
mRNA:decreased expression:brain |
RGD |
PMID:11123717 |
RGD:5509972 |
NCBI chr 1:197,814,409...197,831,802
Ensembl chr 1:197,814,410...197,823,018
|
|
G |
Il10 |
interleukin 10 |
severity treatment |
ISO IDA |
CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:21549006 PMID:23075771 PMID:23971414 |
RGD:7364822, RGD:7364983 |
NCBI chr13:42,472,625...42,477,308
Ensembl chr13:42,472,839...42,477,313
|
|
G |
Il12rb2 |
interleukin 12 receptor subunit beta 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23159883 |
|
NCBI chr 4:96,424,615...96,515,327
Ensembl chr 4:96,426,842...96,515,289
|
|
G |
Il13ra2 |
interleukin 13 receptor subunit alpha 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23159883 |
|
NCBI chr X:111,002,590...111,074,053
Ensembl chr X:111,002,592...111,072,381
|
|
G |
Il16 |
interleukin 16 |
|
IEP |
|
RGD |
PMID:17983426 |
RGD:5024939 |
NCBI chr 1:137,617,702...137,718,022
Ensembl chr 1:137,617,944...137,718,130
|
|
G |
Il17rd |
interleukin 17 receptor D |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23159883 |
|
NCBI chr16:2,228,467...2,295,126
Ensembl chr16:2,228,287...2,292,556
|
|
G |
Il18 |
interleukin 18 |
severity |
IMP ISO |
mRNA, protein:increased expression:brain |
RGD |
PMID:17188500 PMID:17188500 |
RGD:2315917, RGD:2315917 |
NCBI chr 8:50,904,630...50,932,887
Ensembl chr 8:50,906,960...50,932,887
|
|
G |
Il18r1 |
interleukin 18 receptor 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23159883 |
|
NCBI chr 9:42,727,416...42,760,971
Ensembl chr 9:42,727,869...42,760,715
|
|
G |
Il1a |
interleukin 1 alpha |
|
IEP ISO |
mRNA, protein:increased expression:cerebral cortex CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:21549006 PMID:16024175 |
RGD:2311098 |
NCBI chr 3:116,526,601...116,537,055
Ensembl chr 3:116,526,604...116,536,822
|
|
G |
Il1b |
interleukin 1 beta |
|
IEP ISO |
mRNA, protein:increased expression:cerebral cortex CTD Direct Evidence: marker/mechanism protein:increased expression:brain, cerebrospinal fluid mRNA, protein:increased expression:brain |
CTD RGD |
PMID:19800810 PMID:21549006 PMID:16024175 PMID:22503903 PMID:17612572 |
RGD:2311098, RGD:6482651, RGD:1626652 |
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
|
|
G |
Il1r1 |
interleukin 1 receptor type 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21549006 |
|
NCBI chr 9:42,504,917...42,580,958
Ensembl chr 9:42,504,735...42,579,937
|
|
G |
Il1rn |
interleukin 1 receptor antagonist |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:25665855 |
|
NCBI chr 3:7,111,567...7,127,451
Ensembl chr 3:7,111,550...7,127,445
|
|
G |
Il2 |
interleukin 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23159883 |
|
NCBI chr 2:120,004,862...120,009,566
Ensembl chr 2:120,004,862...120,009,566
|
|
G |
Il3 |
interleukin 3 |
disease_progression |
IDA ISO |
protein: increased expression: brain: microdialysis perfusate |
RGD |
PMID:21515263 PMID:20717122 |
RGD:5686795, RGD:5686886 |
NCBI chr10:38,405,716...38,408,066
Ensembl chr10:38,405,716...38,408,066
|
|
G |
Il31ra |
interleukin 31 receptor A |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23159883 |
|
NCBI chr 2:44,118,748...44,189,943
Ensembl chr 2:44,122,624...44,183,767
|
|
G |
Il4 |
interleukin 4 |
|
IEP |
protein:decreased expression:plasma |
RGD |
PMID:24519543 |
RGD:10402802 |
NCBI chr10:37,771,203...37,776,750
Ensembl chr10:37,771,203...37,776,750
|
|
G |
Il5 |
interleukin 5 |
treatment |
IEP |
|
RGD |
PMID:24602693 PMID:24530657 |
RGD:11522766, RGD:11522770 |
NCBI chr10:37,874,342...37,877,213
Ensembl chr10:37,874,342...37,877,213
|
|
G |
Il6 |
interleukin 6 |
|
IEP ISO |
protein:increased expression:cerebrospinal fluid (rat) CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:19800810 PMID:21549006 PMID:23159883 PMID:10027774 |
RGD:11049549 |
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
|
|
G |
Il7 |
interleukin 7 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23159883 |
|
NCBI chr 2:94,235,219...94,280,075
Ensembl chr 2:94,234,766...94,280,075
|
|
G |
Il9r |
interleukin 9 receptor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23159883 |
|
NCBI chr10:15,431,706...15,444,144
Ensembl chr10:15,431,706...15,441,990
|
|
G |
Irf1 |
interferon regulatory factor 1 |
|
IEP ISO |
mRNA:increased expression:cerebral cortex CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:21549006 PMID:12503083 |
RGD:2317873 |
NCBI chr10:37,917,155...37,924,166
Ensembl chr10:37,916,670...37,924,166
|
|
G |
Jak2 |
Janus kinase 2 |
|
IMP |
|
RGD |
PMID:21596098 |
RGD:6483023 |
NCBI chr 1:226,995,334...227,054,381
Ensembl chr 1:226,995,334...227,054,189
|
|
G |
Jun |
Jun proto-oncogene, AP-1 transcription factor subunit |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21549006 |
|
NCBI chr 5:109,894,175...109,897,268
Ensembl chr 5:109,893,145...109,897,656
|
|
G |
Kcnj10 |
potassium inwardly-rectifying channel, subfamily J, member 10 |
|
IEP |
|
RGD |
PMID:20861444 |
RGD:8662901 |
NCBI chr13:84,802,026...84,835,383
Ensembl chr13:84,802,009...84,835,461
|
|
G |
Kdr |
kinase insert domain receptor |
|
IEP IMP |
protein:increased expression:cerebral cortex |
RGD |
PMID:21307798 PMID:19733172 |
RGD:5684382, RGD:5684402 |
NCBI chr14:32,217,871...32,261,018
Ensembl chr14:32,217,871...32,261,018
|
|
G |
Lep |
leptin |
|
IEP |
|
RGD |
PMID:21276361 |
RGD:5128517 |
NCBI chr 4:57,661,127...57,675,262
Ensembl chr 4:57,661,131...57,675,262
|
|
G |
Lsg1 |
large 60S subunit nuclear export GTPase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:14499481 |
|
NCBI chr11:70,132,919...70,168,526
Ensembl chr11:70,143,847...70,168,518
|
|
G |
Ly86 |
lymphocyte antigen 86 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21549006 |
|
NCBI chr17:27,415,807...27,499,695
Ensembl chr17:27,415,830...27,487,260
|
|
G |
Mag |
myelin-associated glycoprotein |
susceptibility |
IMP |
|
RGD |
PMID:17156367 |
RGD:9685230 |
NCBI chr 1:86,148,227...86,163,726
Ensembl chr 1:86,148,228...86,163,656
|
|
G |
Map1b |
microtubule-associated protein 1B |
|
IEP |
protein:increased expression, increased phosphorylation:brain |
RGD |
PMID:10906717 |
RGD:2304029 |
NCBI chr 2:30,817,261...30,910,458
Ensembl chr 2:30,817,261...30,910,317
|
|
G |
Map1lc3a |
microtubule-associated protein 1 light chain 3 alpha |
|
IEP |
|
RGD |
PMID:24221859 |
RGD:11558018 |
NCBI chr 3:143,783,024...143,784,670
Ensembl chr 3:143,783,024...143,784,670
|
|
G |
Map2 |
microtubule-associated protein 2 |
|
IEP IDA |
protein:decreased expression:cerebral cortex, neuron |
RGD |
PMID:21401443 PMID:20568963 |
RGD:6483087, RGD:6483089 |
NCBI chr 9:67,723,422...67,981,886
Ensembl chr 9:67,723,371...67,979,809
|
|
G |
Map3k7 |
mitogen activated protein kinase kinase kinase 7 |
treatment |
IEP ISO IMP |
associated with Subarachnoid Hemorrhage |
RGD |
PMID:27000704 PMID:33414375 PMID:26100626 |
RGD:155791672, RGD:155882440, RGD:155804286 |
NCBI chr 5:46,356,973...46,415,597
Ensembl chr 5:46,357,931...46,415,597
|
|
G |
Mbl2 |
mannose binding lectin 2 |
disease_progression |
ISO |
|
RGD |
PMID:18183030 |
RGD:12910935 |
NCBI chr 1:228,016,439...228,024,736
|
|
G |
Mbp |
myelin basic protein |
|
IDA |
|
RGD |
PMID:18583256 |
RGD:7349333 |
NCBI chr18:75,855,878...75,966,404
Ensembl chr18:75,855,878...75,966,404
|
|
G |
Mdm2 |
MDM2 proto-oncogene |
|
IEP |
protein:increased expression:brain cortex (rat) |
RGD |
PMID:15165363 |
RGD:2317397 |
NCBI chr 7:53,290,660...53,315,205
Ensembl chr 7:53,290,664...53,314,915
|
|
G |
Mif |
macrophage migration inhibitory factor |
|
IEP |
|
RGD |
PMID:15922484 |
RGD:1641989 |
NCBI chr20:12,790,919...12,791,784
Ensembl chr20:12,790,902...12,799,504
|
|
G |
Mir132 |
microRNA 132 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23159883 |
|
NCBI chr10:60,023,696...60,023,796
Ensembl chr10:60,023,696...60,023,796
|
|
G |
Mir144 |
microRNA 144 |
|
IEP |
|
RGD |
PMID:25089700 |
RGD:11576302 |
NCBI chr10:62,961,348...62,961,430
Ensembl chr10:62,961,348...62,961,430
|
|
G |
Mir153 |
microRNA 153 |
|
IEP |
|
RGD |
PMID:25089700 |
RGD:11576302 |
NCBI chr 6:138,163,595...138,163,681
Ensembl chr 6:138,163,595...138,163,681
|
|
G |
Mir183 |
microRNA 183 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23159883 |
|
NCBI chr 4:58,788,614...58,788,723
Ensembl chr 4:58,788,614...58,788,723
|
|
G |
Mmp9 |
matrix metallopeptidase 9 |
treatment |
IDA IMP ISO |
CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:19631748 PMID:16671440 PMID:24661104 |
RGD:1582656, RGD:13207312 |
NCBI chr 3:153,684,158...153,692,118
Ensembl chr 3:153,683,858...153,692,120
|
|
G |
Mpo |
myeloperoxidase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23159883 |
|
NCBI chr10:72,594,458...72,608,862
Ensembl chr10:72,594,661...72,604,819
|
|
G |
Mt-co2 |
mitochondrially encoded cytochrome c oxidase II |
|
IEP |
mRNA, protein:increased expression:hippocampus |
RGD |
PMID:11686499 |
RGD:2302298 |
NCBI chr MT:7,006...7,689
Ensembl chr MT:7,006...7,689
|
|
G |
Mt2A |
metallothionein 2A |
|
ISO IEP |
mRNA:increased expression:liver (mouse) mRNA:increased expression:dentate gyrus (rat) |
RGD |
PMID:22363575 PMID:15650329 |
RGD:6483812, RGD:6483847 |
NCBI chr19:10,832,009...10,832,783
Ensembl chr19:10,832,002...10,832,784
|
|
G |
Mt3 |
metallothionein 3 |
treatment |
IDA IEP |
|
RGD |
PMID:16314047 PMID:10595827 PMID:10218634 |
RGD:6480628, RGD:9685805, RGD:9685803 |
NCBI chr19:10,848,754...10,850,158
Ensembl chr19:10,848,755...10,850,158
|
|
G |
Myoc |
myocilin |
|
IEP |
mRNA:increased expression:cerebral cortex (rat) |
RGD |
PMID:12799138 |
RGD:7401267 |
NCBI chr13:74,976,730...74,987,128
Ensembl chr13:74,976,730...74,987,127
|
|
G |
Nfe2l2 |
NFE2 like bZIP transcription factor 2 |
|
IEP |
protein:increased expression:lung: |
RGD |
PMID:18787991 PMID:25089700 |
RGD:5134971, RGD:11576302 |
NCBI chr 3:60,594,239...60,621,785
Ensembl chr 3:60,594,242...60,621,737
|
|
G |
Ngb |
neuroglobin |
severity |
IEP |
|
RGD |
PMID:21915648 |
RGD:9743963 |
NCBI chr 6:106,744,378...106,749,830
Ensembl chr 6:106,744,378...106,749,830
|
|
G |
Ngfr |
nerve growth factor receptor |
treatment |
IDA |
|
RGD |
PMID:23940017 |
RGD:10414074 |
NCBI chr10:80,515,287...80,533,518
Ensembl chr10:80,515,299...80,533,518
|
|
G |
Nos2 |
nitric oxide synthase 2 |
|
IEP |
|
RGD |
PMID:11526986 |
RGD:10395358 |
NCBI chr10:63,815,308...63,851,208
Ensembl chr10:63,815,308...63,851,210
|
|
G |
Nppb |
natriuretic peptide B |
|
ISO |
associated with lung diseases;protein:increased expression:serum: CTD Direct Evidence: therapeutic |
CTD RGD |
PMID:19803787 PMID:23837838 |
RGD:7247620 |
NCBI chr 5:158,416,813...158,418,175
Ensembl chr 5:158,416,866...158,418,168
|
|
G |
Npy |
neuropeptide Y |
|
IEP |
protein:increased expression:adrenal medulla |
RGD |
PMID:23570732 |
RGD:10448961 |
NCBI chr 4:78,881,294...78,888,495
Ensembl chr 4:78,881,264...78,888,495
|
|
G |
Nqo1 |
NAD(P)H quinone dehydrogenase 1 |
treatment |
IEP |
mRNA:increased expression:lung associated with Subarachnoid Hemorrhage |
RGD |
PMID:18787991 PMID:20864352 |
RGD:5134971, RGD:11035222 |
NCBI chr19:35,295,633...35,310,528
Ensembl chr19:35,295,573...35,310,557
|
|
G |
Nt5e |
5' nucleotidase, ecto |
|
IEP |
protein:altered expression:cerebral cortex (rat) |
RGD |
PMID:21337375 |
RGD:5134348 |
NCBI chr 8:89,271,046...89,314,918
Ensembl chr 8:89,270,696...89,314,881
|
|
G |
P2ry1 |
purinergic receptor P2Y1 |
|
IEP |
protein:increased expression:brain, astrocyte |
RGD |
PMID:19115395 |
RGD:2315811 |
NCBI chr 2:145,241,975...145,248,186
Ensembl chr 2:145,241,849...145,248,457
|
|
G |
Palld |
palladin, cytoskeletal associated protein |
|
IEP |
protein:increased expression:brain, astrocyte |
RGD |
PMID:12932445 |
RGD:2325786 |
NCBI chr16:28,228,006...28,621,349
Ensembl chr16:27,981,354...28,621,337
|
|
G |
Parp1 |
poly (ADP-ribose) polymerase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17640816 |
|
NCBI chr13:92,307,593...92,339,406
Ensembl chr13:92,307,586...92,339,404
|
|
G |
Pawr |
pro-apoptotic WT1 regulator |
|
IEP |
mRNA,protein:increased expression:brain: |
RGD |
PMID:11421591 |
RGD:9835358 |
NCBI chr 7:43,645,028...43,725,033
Ensembl chr 7:43,645,084...43,725,028
|
|
G |
Pde4d |
phosphodiesterase 4D |
|
IEP |
mRNA, protein:alternative form, decreased phosphorylation:brain |
RGD |
PMID:23057870 |
RGD:7327147 |
NCBI chr 2:40,014,933...41,529,190
Ensembl chr 2:40,019,933...41,525,884
|
|
G |
Pdgfa |
platelet derived growth factor subunit A |
|
IEP |
mRNA:increased expression:cerebral cortex, hippocampus |
RGD |
PMID:9645955 |
RGD:11084932 |
NCBI chr12:15,645,549...15,667,056
Ensembl chr12:15,645,541...15,666,497
|
|
G |
Pdgfb |
platelet derived growth factor subunit B |
|
IEP |
mRNA:increased expression:cerebral cortex, hippocampus |
RGD |
PMID:9645955 |
RGD:11084932 |
NCBI chr 7:111,539,444...111,557,984
Ensembl chr 7:111,540,345...111,557,984
|
|
G |
Pdgfra |
platelet derived growth factor receptor alpha |
|
IEP |
mRNA:increased expression:cerebral cortex, hippocampus |
RGD |
PMID:9645955 |
RGD:11084932 |
NCBI chr14:33,005,838...33,054,347
Ensembl chr14:33,005,839...33,054,335
|
|
G |
Pdgfrb |
platelet derived growth factor receptor beta |
|
IEP |
mRNA:increased expression:cerebral cortex, hippocampus |
RGD |
PMID:9645955 |
RGD:11084932 |
NCBI chr18:54,500,002...54,538,843
Ensembl chr18:54,499,964...54,538,843
|
|
G |
Pecam1 |
platelet and endothelial cell adhesion molecule 1 |
|
IDA |
|
RGD |
PMID:22658532 |
RGD:6484732 |
NCBI chr10:91,590,521...91,652,279
Ensembl chr10:91,590,521...91,652,116
|
|
G |
Pglyrp1 |
peptidoglycan recognition protein 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21549006 |
|
NCBI chr 1:78,531,815...78,537,001
Ensembl chr 1:78,531,815...78,537,001
|
|
G |
Pgr |
progesterone receptor |
|
IEP |
|
RGD |
PMID:23211561 |
RGD:7248711 |
NCBI chr 8:6,073,216...6,131,552
Ensembl chr 8:6,072,673...6,131,344
|
|
G |
Phb1 |
prohibitin 1 |
|
IEP |
protein:increased oxidation:cerebral cortex |
RGD |
PMID:17518533 |
RGD:2292409 |
NCBI chr10:80,605,268...80,618,043
Ensembl chr10:80,605,251...80,618,042
|
|
G |
Phb2 |
prohibitin 2 |
|
IEP |
|
RGD |
PMID:24566151 |
RGD:12903261 |
NCBI chr 4:157,517,662...157,522,268
Ensembl chr 4:157,517,577...157,522,272
|
|
G |
Pias1 |
protein inhibitor of activated STAT, 1 |
|
IEP |
protein:decreased expression:brain, nucleus |
RGD |
PMID:21545521 |
RGD:8693413 |
NCBI chr 8:63,338,150...63,451,670
Ensembl chr 8:63,338,150...63,438,905
|
|
G |
Ppara |
peroxisome proliferator activated receptor alpha |
|
IDA |
agonist more effective in combination with simvastatin |
RGD |
PMID:18562561 |
RGD:5508455 |
NCBI chr 7:116,832,405...116,900,878
Ensembl chr 7:116,832,756...116,895,346
|
|
G |
Ppargc1a |
PPARG coactivator 1 alpha |
treatment |
ISO IEP |
protein:decreased expression:frontal cortex (rat) |
RGD |
PMID:22642418 PMID:24345766 |
RGD:6484257, RGD:10059630 |
NCBI chr14:58,860,752...59,516,525
Ensembl chr14:58,861,144...59,512,656
|
|
G |
Ppp3ca |
protein phosphatase 3 catalytic subunit alpha |
|
IEP ISO |
protein: :hippocampus CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:14499481 PMID:19751097 |
RGD:6483311 |
NCBI chr 2:225,165,981...225,440,978
Ensembl chr 2:225,165,766...225,438,974
|
|
G |
Prf1 |
perforin 1 |
|
ISO |
|
RGD |
PMID:20537642 |
RGD:6482807 |
NCBI chr20:29,246,202...29,251,712
Ensembl chr20:29,246,202...29,251,701
|
|
G |
Ptger3 |
prostaglandin E receptor 3 |
|
IEP |
protein:increased expression:striatum, microglia (rat) |
RGD |
PMID:15234107 |
RGD:9850280 |
NCBI chr 2:246,606,131...246,750,970
Ensembl chr 2:246,606,183...246,684,434
|
|
G |
Ptgs1 |
prostaglandin-endoperoxide synthase 1 |
|
ISO IEP |
protein:increased expression:microglia, macrophage protein:increased expression:microglial cells, macrophage, endothelial cell |
RGD |
PMID:19719848 PMID:11565600 PMID:12005397 |
RGD:5688162, RGD:5688242, RGD:5688239 |
NCBI chr 3:19,584,015...19,605,589
Ensembl chr 3:19,584,015...19,605,586
|
|
G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
IMP ISO |
CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:12410334 PMID:20810888 PMID:21549006 PMID:21866634 PMID:19719848 |
RGD:5508191, RGD:5688162 |
NCBI chr13:62,164,080...62,169,770
Ensembl chr13:62,163,932...62,172,188
|
|
G |
Ptprz1 |
protein tyrosine phosphatase, receptor type Z1 |
|
IEP |
|
RGD |
PMID:12088737 |
RGD:727637 |
NCBI chr 4:51,397,316...51,595,220
Ensembl chr 4:51,397,601...51,595,218
|
|
G |
Rchy1 |
ring finger and CHY zinc finger domain containing 1 |
|
IEP |
protein:increased expression:cerebral cortex |
RGD |
PMID:21728064 |
RGD:10045359 |
NCBI chr14:16,113,263...16,129,017
Ensembl chr14:16,113,224...16,129,167
|
|
G |
Reg3b |
regenerating family member 3 beta |
|
IEP |
mRNA:increased expression:cerebral cortex (rat) |
RGD |
PMID:19351265 |
RGD:9831399 |
NCBI chr 4:110,861,775...110,865,015
Ensembl chr 4:110,861,775...110,865,015
|
|
G |
Rela |
RELA proto-oncogene, NF-kB subunit |
|
IEP |
protein:increased expression:ileum |
RGD |
PMID:18288455 |
RGD:2298787 |
NCBI chr 1:202,925,001...202,935,484
Ensembl chr 1:202,924,945...202,935,484
|
|
G |
Ret |
ret proto-oncogene |
|
IEP |
mRNA:increased expression:brain |
RGD |
PMID:18501516 |
RGD:2324932 |
NCBI chr 4:151,325,969...151,368,176
Ensembl chr 4:151,326,431...151,368,176
|
|
G |
Rhoa |
ras homolog family member A |
|
IEP |
protein:increased expression:microglial cell, brain |
RGD |
PMID:17929039 |
RGD:2298888 |
NCBI chr 8:108,991,926...109,025,746
Ensembl chr 8:108,991,954...109,025,746
|
|
G |
Robo1 |
roundabout guidance receptor 1 |
|
IEP |
mRNA:increased expression:brain |
RGD |
PMID:16262652 |
RGD:2316136 |
NCBI chr11:10,580,863...11,621,672
Ensembl chr11:10,580,908...11,620,203
|
|
G |
Robo2 |
roundabout guidance receptor 2 |
|
IEP |
mRNA:increased expression:brain |
RGD |
PMID:16262652 |
RGD:2316136 |
NCBI chr11:12,528,949...14,096,726
Ensembl chr11:12,528,951...13,041,536
|
|
G |
Robo3 |
roundabout guidance receptor 3 |
|
IEP |
mRNA:increased expression:brain |
RGD |
PMID:16262652 |
RGD:2316136 |
NCBI chr 8:37,133,542...37,151,674
Ensembl chr 8:37,133,916...37,151,315
|
|
G |
Rps27a |
ribosomal protein S27a |
|
IEP |
mRNA:decreased expression:cerebral cortex, hippocampus |
RGD |
PMID:17936732 |
RGD:11041870 |
NCBI chr14:103,285,734...103,288,011
Ensembl chr14:103,285,734...103,288,011
|
|
G |
S100b |
S100 calcium binding protein B |
severity |
ISO |
CTD Direct Evidence: marker/mechanism|therapeutic |
CTD RGD |
PMID:11520488 PMID:21783483 PMID:21976236 |
RGD:5508761 |
NCBI chr20:12,372,866...12,381,619
Ensembl chr20:12,372,881...12,394,743
|
|
G |
Sele |
selectin E |
|
IEP |
protein:increased expression:brain |
RGD |
PMID:19107536 |
RGD:2313599 |
NCBI chr13:76,402,841...76,412,741
Ensembl chr13:76,403,304...76,412,741
|
|
G |
Serpinc1 |
serpin family C member 1 |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:21534203 |
|
NCBI chr13:73,257,208...73,271,476
Ensembl chr13:73,257,179...73,284,293
|
|
G |
Serpinf1 |
serpin family F member 1 |
treatment |
ISO IEP |
human gene in a rat model protein:altered expression:cerebellum (rat) |
RGD |
PMID:20142768 PMID:17709187 |
RGD:8612994, RGD:8622925 |
NCBI chr10:60,250,198...60,262,593
Ensembl chr10:60,249,708...60,262,646
|
|
G |
Sirt1 |
sirtuin 1 |
treatment |
IEP |
|
RGD |
PMID:17970622 |
RGD:9497541 |
NCBI chr20:25,307,143...25,329,260
Ensembl chr20:25,306,917...25,329,260
|
|
G |
Skp2 |
S-phase kinase associated protein 2 |
|
IEP |
protein:increased expression:brain |
RGD |
PMID:19852587 |
RGD:2315049 |
NCBI chr 2:58,161,226...58,189,293
Ensembl chr 2:58,161,229...58,189,338
|
|
G |
Slc18a3 |
solute carrier family 18 member A3 |
|
IEP |
protein:decreased expression:brain |
RGD |
PMID:18848922 |
RGD:5686682 |
NCBI chr16:7,713,630...7,716,491
|
|
G |
Slit1 |
slit guidance ligand 1 |
|
IEP |
mRNA:increased expression:brain |
RGD |
PMID:16262652 |
RGD:2316136 |
NCBI chr 1:240,409,559...240,558,127
Ensembl chr 1:240,409,561...240,558,127
|
|
G |
Slit3 |
slit guidance ligand 3 |
|
IEP |
mRNA:increased expression:brain |
RGD |
PMID:16262652 |
RGD:2316136 |
NCBI chr10:19,571,798...20,156,634
Ensembl chr10:19,571,684...20,156,634
|
|
G |
Snca |
synuclein alpha |
|
ISO IEP |
|
RGD |
PMID:14637093 PMID:25089700 |
RGD:6480195, RGD:11576302 |
NCBI chr 4:89,696,420...89,797,240
Ensembl chr 4:89,696,420...89,796,262
|
|
G |
Sncb |
synuclein, beta |
|
ISO |
|
RGD |
PMID:14637093 |
RGD:6480195 |
NCBI chr17:9,846,802...9,855,013
Ensembl chr17:9,846,802...9,855,012
|
|
G |
Sncg |
synuclein, gamma |
|
ISO |
|
RGD |
PMID:14637093 |
RGD:6480195 |
NCBI chr16:9,700,513...9,705,751
Ensembl chr16:9,700,514...9,705,368
|
|
G |
Snw1 |
SNW domain containing 1 |
|
IEP |
mRNA, protein:increased expression:cerebral cortex (rat) |
RGD |
PMID:22965216 |
RGD:11035237 |
NCBI chr 6:107,095,450...107,119,536
Ensembl chr 6:107,095,457...107,119,536
|
|
G |
Sod1 |
superoxide dismutase 1 |
|
ISO |
|
RGD |
PMID:16248885 |
RGD:1581214 |
NCBI chr11:29,456,673...29,462,249
Ensembl chr11:29,456,558...29,462,249
|
|
G |
Sod2 |
superoxide dismutase 2 |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD RGD |
PMID:24462953 PMID:16248885 |
RGD:1581214 |
NCBI chr 1:47,638,318...47,645,163
Ensembl chr 1:47,636,528...47,645,189
|
|
G |
Sparc |
secreted protein acidic and cysteine rich |
|
IEP |
mRNA:increased expression:brain, blood vessel |
RGD |
PMID:9704602 |
RGD:2300066 |
NCBI chr10:39,516,394...39,538,252
Ensembl chr10:39,516,406...39,538,396
|
|
G |
Sstr2 |
somatostatin receptor 2 |
|
IEP |
|
RGD |
PMID:11879809 |
RGD:2325002 |
NCBI chr10:98,664,204...98,671,370
Ensembl chr10:98,664,216...98,674,351
|
|
G |
Sstr3 |
somatostatin receptor 3 |
|
IEP |
|
RGD |
PMID:11879809 |
RGD:2325002 |
NCBI chr 7:110,092,563...110,109,043
Ensembl chr 7:110,092,575...110,099,769
|
|
G |
Sstr4 |
somatostatin receptor 4 |
|
IEP |
|
RGD |
PMID:11879809 |
RGD:2325002 |
NCBI chr 3:135,854,826...135,856,689
Ensembl chr 3:135,854,826...135,856,689
|
|
G |
Stat1 |
signal transducer and activator of transcription 1 |
|
IMP |
|
RGD |
PMID:21596098 |
RGD:6483023 |
NCBI chr 9:49,419,561...49,459,969
Ensembl chr 9:49,419,340...49,588,540
|
|
G |
Stat3 |
signal transducer and activator of transcription 3 |
|
IMP IDA |
protein:increased phosphorylation:brain |
RGD |
PMID:21596098 PMID:22145815 PMID:22827467 |
RGD:6483023, RGD:8694312, RGD:6892706 |
NCBI chr10:85,811,206...85,863,057
Ensembl chr10:85,811,218...85,863,057
|
|
G |
Strn |
striatin |
|
IEP |
|
RGD |
PMID:16351572 |
RGD:2311293 |
NCBI chr 6:16,335,265...16,422,159
Ensembl chr 6:16,335,358...16,417,083
|
|
G |
Tardbp |
TAR DNA binding protein |
|
ISO |
|
RGD |
PMID:22101322 |
RGD:5687195 |
NCBI chr 5:159,050,518...159,062,218
Ensembl chr 5:159,051,799...159,062,055
|
|
G |
Tf |
transferrin |
|
IEP |
|
RGD |
PMID:22538758 |
RGD:7244386 |
NCBI chr 8:103,789,780...103,816,487
Ensembl chr 8:103,767,995...103,816,511
|
|
G |
Th |
tyrosine hydroxylase |
|
IEP |
protein:decreased activity:striatum (rat) |
RGD |
PMID:21047500 |
RGD:5128822 |
NCBI chr 1:198,071,500...198,078,832
Ensembl chr 1:198,071,503...198,109,767
|
|
G |
Thbd |
thrombomodulin |
onset |
ISO |
|
RGD |
PMID:17895610 |
RGD:5685007 |
NCBI chr 3:135,863,366...135,867,018
Ensembl chr 3:135,862,835...135,867,193
|
|
G |
Ticam2 |
TIR domain containing adaptor molecule 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21549006 |
|
NCBI chr18:39,289,902...39,311,462
Ensembl chr18:39,294,453...39,311,462
|
|
G |
Timp1 |
TIMP metallopeptidase inhibitor 1 |
|
IEP |
mRNA:increased expression:brain, astrocytes |
RGD |
PMID:10719361 |
RGD:2290468 |
NCBI chr X:1,212,969...1,217,714
Ensembl chr X:1,212,972...1,217,664
|
|
G |
Timp2 |
TIMP metallopeptidase inhibitor 2 |
|
IEP |
mRNA:increased expression:brain, neuron, microglial cell |
RGD |
PMID:10719361 |
RGD:2290468 |
NCBI chr10:103,541,199...103,590,611
Ensembl chr10:103,531,505...103,590,611
|
|
G |
Tjp1 |
tight junction protein 1 |
|
IEP |
|
RGD |
PMID:19889224 |
RGD:2325128 |
NCBI chr 1:118,849,838...119,094,492
Ensembl chr 1:118,849,838...119,094,432
|
|
G |
Tlr1 |
toll-like receptor 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21549006 |
|
NCBI chr14:43,384,127...43,396,765
Ensembl chr14:43,384,932...43,397,125
|
|
G |
Tlr2 |
toll-like receptor 2 |
|
IEP ISO |
mRNA:increased expression:brain CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:21549006 PMID:18316784 |
RGD:2312713 |
NCBI chr 2:169,200,620...169,206,819
Ensembl chr 2:169,197,419...169,206,630
|
|
G |
Tlr4 |
toll-like receptor 4 |
|
IEP ISO |
mRNA:increased expression:brain CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:21549006 PMID:18316784 |
RGD:2312713 |
NCBI chr 5:80,145,867...80,159,501
Ensembl chr 5:80,145,826...80,159,628
|
|
G |
Tlr9 |
toll-like receptor 9 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21549006 |
|
NCBI chr 8:106,864,680...106,868,796
Ensembl chr 8:106,864,680...106,868,796
|
|
G |
Tnf |
tumor necrosis factor |
|
ISO IMP |
CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:19800810 PMID:21549006 PMID:10674461 |
RGD:13825262 |
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
|
|
G |
Tnfrsf13b |
TNF receptor superfamily member 13B |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23159883 |
|
NCBI chr10:45,801,860...45,824,932
Ensembl chr10:45,801,860...45,822,987
|
|
G |
Tnfrsf13c |
TNF receptor superfamily member 13C |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23159883 |
|
NCBI chr 7:113,736,046...113,738,523
Ensembl chr 7:113,736,055...113,738,517
|
|
G |
Tnfrsf14 |
TNF receptor superfamily member 14 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23159883 |
|
NCBI chr 5:165,486,069...165,494,421
Ensembl chr 5:165,484,262...165,493,703
|
|
G |
Tnfrsf1a |
TNF receptor superfamily member 1A |
|
IEP ISO |
protein:increased expression:brain CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:21549006 PMID:17074049 |
RGD:1624183 |
NCBI chr 4:158,150,815...158,163,592
Ensembl chr 4:158,150,820...158,163,591
|
|
G |
Tnfsf10 |
TNF superfamily member 10 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23159883 |
|
NCBI chr 2:110,199,835...110,227,239
Ensembl chr 2:110,207,916...110,225,135
|
|
G |
Tnfsf12 |
TNF superfamily member 12 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23159883 |
|
NCBI chr10:54,403,870...54,413,213
Ensembl chr10:54,403,870...54,413,213
|
|
G |
Traf4 |
Tnf receptor associated factor 4 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23159883 |
|
NCBI chr10:63,054,169...63,060,284
Ensembl chr10:63,054,181...63,060,284
|
|
G |
Trpm2 |
transient receptor potential cation channel, subfamily M, member 2 |
|
IEP |
mRNA, protein:increased expression:cerebral cortex, hippocampus |
RGD |
PMID:20309649 |
RGD:9999437 |
NCBI chr20:10,703,568...10,753,189
Ensembl chr20:10,707,014...10,753,181
|
|
G |
Uba52 |
ubiquitin A-52 residue ribosomal protein fusion product 1 |
|
IEP |
mRNA:decreased expression:cerebral cortex, hippocampus (rat) |
RGD |
PMID:17936732 |
RGD:11041870 |
NCBI chr16:18,918,614...18,920,807
Ensembl chr16:18,900,616...18,920,807
|
|
G |
Ucp2 |
uncoupling protein 2 |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD RGD |
PMID:12858170 PMID:12858170 |
RGD:7204436 |
NCBI chr 1:154,839,242...154,845,612
Ensembl chr 1:154,839,209...154,845,611
|
|
G |
Vegfa |
vascular endothelial growth factor A |
|
IEP ISO |
CTD Direct Evidence: therapeutic |
CTD RGD |
PMID:18065154 PMID:12230324 |
RGD:1580574 |
NCBI chr 9:14,955,300...14,970,641
Ensembl chr 9:14,955,300...14,970,641
|
|
G |
Vegfb |
vascular endothelial growth factor B |
|
IEP |
mRNA, protein:increased expression:brain |
RGD |
PMID:12230324 |
RGD:1580574 |
NCBI chr 1:204,172,297...204,178,046
Ensembl chr 1:204,172,225...204,177,944
|
|
G |
Vim |
vimentin |
|
ISO IEP |
protein:increased expression:brain |
RGD |
PMID:19728994 PMID:15527750 |
RGD:6480519, RGD:6480527 |
NCBI chr17:76,668,701...76,677,186
Ensembl chr17:76,668,647...76,677,187
|
|
G |
Xdh |
xanthine dehydrogenase |
treatment |
IEP |
|
RGD |
PMID:26528358 |
RGD:13208950 |
NCBI chr 6:21,530,463...21,592,172
Ensembl chr 6:21,530,113...21,592,268
|
|
|
G |
Bax |
BCL2 associated X, apoptosis regulator |
|
IEP |
|
RGD |
PMID:26431790 |
RGD:11537057 |
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
|
|
G |
Bid |
BH3 interacting domain death agonist |
|
IEP |
|
RGD |
PMID:26431790 |
RGD:11537057 |
NCBI chr 4:154,113,198...154,136,353
Ensembl chr 4:154,113,198...154,134,720
|
|
G |
Casp3 |
caspase 3 |
|
IEP |
|
RGD |
PMID:26431790 |
RGD:11537057 |
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
|
|
G |
Casp8 |
caspase 8 |
|
IEP |
|
RGD |
PMID:26431790 |
RGD:11537057 |
NCBI chr 9:60,263,863...60,312,542
Ensembl chr 9:60,264,075...60,312,542
|
|
G |
Casp9 |
caspase 9 |
|
IEP |
|
RGD |
PMID:26431790 |
RGD:11537057 |
NCBI chr 5:154,108,872...154,126,628
Ensembl chr 5:154,109,046...154,126,626
|
|
G |
Cat |
catalase |
|
IDA |
|
RGD |
PMID:19693467 |
RGD:5130750 |
NCBI chr 3:89,842,393...89,874,577
Ensembl chr 3:89,842,399...89,874,478
|
|
G |
Ccl7 |
C-C motif chemokine ligand 7 |
|
ISO |
|
RGD |
PMID:16888287 |
RGD:5130981 |
NCBI chr10:67,016,446...67,018,296
Ensembl chr10:67,016,446...67,018,303
|
|
G |
Cd209c |
CD209c molecule |
|
ISO |
|
RGD |
PMID:20050784 |
RGD:5131185 |
NCBI chr12:1,936,233...1,943,841
Ensembl chr12:1,936,396...1,942,040
|
|
G |
Cd209d |
CD209d molecule |
|
ISO |
|
RGD |
PMID:20050784 |
RGD:5131185 |
NCBI chr12:1,891,109...1,897,559
Ensembl chr12:1,891,113...1,901,171
|
|
G |
Chi3l1 |
chitinase 3 like 1 |
|
ISO |
protein:decreased secretion:lung, secretion (human) |
RGD |
PMID:20558631 |
RGD:4892651 |
NCBI chr13:45,641,802...45,649,787
Ensembl chr13:45,641,802...45,649,787
|
|
G |
Cxcl1 |
C-X-C motif chemokine ligand 1 |
|
IEP |
|
RGD |
PMID:19951473 |
RGD:5134972 |
NCBI chr14:17,193,364...17,195,143
Ensembl chr14:17,193,365...17,195,215
|
|
G |
Dag1 |
dystroglycan 1 |
|
ISO |
DNA:SNP: :p.N494H (human) |
RGD |
PMID:17196572 |
RGD:11537474 |
NCBI chr 8:108,890,926...108,955,611
Ensembl chr 8:108,890,929...108,952,325
|
|
G |
Edn1 |
endothelin 1 |
|
IEP |
protein:increased expression:lung (rat) |
RGD |
PMID:20647310 |
RGD:4144841 |
NCBI chr17:22,454,924...22,460,812
Ensembl chr17:22,454,420...22,460,885
|
|
G |
Epas1 |
endothelial PAS domain protein 1 |
treatment |
IEP |
|
RGD |
PMID:23065129 |
RGD:10395385 |
NCBI chr 6:7,790,236...7,871,246
Ensembl chr 6:7,790,647...7,871,228
|
|
G |
Flt1 |
Fms related receptor tyrosine kinase 1 |
|
ISO |
|
RGD |
PMID:22003089 |
RGD:10402122 |
NCBI chr12:7,296,899...7,468,626
Ensembl chr12:7,297,292...7,468,626
|
|
G |
Gstm1 |
glutathione S-transferase mu 1 |
susceptibility |
ISO |
DNA:deletion, haplotype:: (human) |
RGD |
PMID:24120392 |
RGD:12792215 |
NCBI chr 2:195,649,845...195,655,402
Ensembl chr 2:195,649,845...195,655,411
|
|
G |
Gstp1 |
glutathione S-transferase pi 1 |
susceptibility |
ISO |
DNA:polymorphism:exon:p.I105V (human) |
RGD |
PMID:14726935 |
RGD:4142520 |
NCBI chr 1:201,337,762...201,340,230
Ensembl chr 1:201,321,672...201,340,226
|
|
G |
Gstt1 |
glutathione S-transferase theta 1 |
susceptibility |
ISO |
DNA:deletion, haplotype:: (human) |
RGD |
PMID:24120392 |
RGD:12792215 |
NCBI chr20:12,856,613...12,873,586
Ensembl chr20:12,856,669...12,873,585
|
|
G |
Hif1a |
hypoxia inducible factor 1 subunit alpha |
treatment |
IEP |
|
RGD |
PMID:23065129 PMID:26431790 |
RGD:10395385, RGD:11537057 |
NCBI chr 6:92,624,059...92,669,262
Ensembl chr 6:92,624,390...92,669,261
|
|
G |
Il1b |
interleukin 1 beta |
|
ISO |
protein:increased expression:lung CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:16813970 PMID:15539764 |
RGD:4143172 |
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
|
|
G |
Il1rn |
interleukin 1 receptor antagonist |
susceptibility |
ISO |
protein:increased expression:lung associated with Premature Birth;DNA:polymorphism:: |
RGD |
PMID:15539764 PMID:22882323 |
RGD:4143172, RGD:12910846 |
NCBI chr 3:7,111,567...7,127,451
Ensembl chr 3:7,111,550...7,127,445
|
|
G |
Itga3 |
integrin subunit alpha 3 |
|
ISO |
ClinVar Annotator: match by term: Bronchopulmonary dysplasia |
ClinVar |
PMID:25741868 |
|
NCBI chr10:79,990,160...80,022,206
Ensembl chr10:79,990,161...80,022,118
|
|
G |
Mbl2 |
mannose binding lectin 2 |
susceptibility |
ISO |
associated with Premature Birth;DNA:polymorphism:exon: |
RGD |
PMID:22882323 |
RGD:12910846 |
NCBI chr 1:228,016,439...228,024,736
|
|
G |
Mif |
macrophage migration inhibitory factor |
|
ISO |
associated with Respiratory Distress Syndrome, Newborn; protein:increased expression:lung |
RGD |
PMID:18097062 |
RGD:4891007 |
NCBI chr20:12,790,919...12,791,784
Ensembl chr20:12,790,902...12,799,504
|
|
G |
Mmp9 |
matrix metallopeptidase 9 |
|
ISO |
|
RGD |
PMID:19097983 |
RGD:5129685 |
NCBI chr 3:153,684,158...153,692,118
Ensembl chr 3:153,683,858...153,692,120
|
|
G |
Muc1 |
mucin 1, cell surface associated |
severity |
ISO |
protein:increased expression:cord plasma |
RGD |
PMID:18025794 |
RGD:5131170 |
NCBI chr 2:174,635,559...174,640,738
Ensembl chr 2:174,635,995...174,640,733
|
|
G |
Nfkbia |
NFKB inhibitor alpha |
exacerbates |
ISO |
DNA:SNPs:promoter: (rs2233406, rs2233409) (human) |
RGD |
PMID:23487427 |
RGD:40902982 |
NCBI chr 6:72,858,713...72,861,941
Ensembl chr 6:72,858,712...72,861,941
|
|
G |
Postn |
periostin |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:22363622 |
|
NCBI chr 2:138,527,714...138,559,098
Ensembl chr 2:138,527,696...138,559,099
|
|
G |
Scgb1a1 |
secretoglobin family 1A member 1 |
|
ISO |
|
RGD |
PMID:11435254 |
RGD:5144211 |
NCBI chr 1:205,977,060...205,980,610
Ensembl chr 1:205,977,060...205,980,610
|
|
G |
Serpine1 |
serpin family E member 1 |
|
ISO |
associated with Premature Birth;protein:increased expression:blood: |
RGD |
PMID:25140773 |
RGD:13208551 |
NCBI chr12:19,601,272...19,611,657
Ensembl chr12:19,601,272...19,611,657
|
|
G |
Sftpa1 |
surfactant protein A1 |
susceptibility |
ISO |
DNA:snps, haplotypes:multiple (human) DNA:polymorphisms, haplotype: (human) |
RGD |
PMID:17264398 PMID:11105614 |
RGD:4143384, RGD:4144876 |
NCBI chr16:17,008,180...17,011,686
Ensembl chr16:17,008,180...17,011,685
|
|
G |
Sftpb |
surfactant protein B |
susceptibility |
ISO |
DNA:deletion:intron (human) DNA:SNPs:5'UTR,exon: DNA:polymorphism:intron (human) |
RGD |
PMID:15102713 PMID:26045806 PMID:17264398 PMID:12424586 |
RGD:4143405, RGD:11085373, RGD:4143384, RGD:4143418 |
NCBI chr 4:104,359,303...104,368,439
Ensembl chr 4:104,359,396...104,368,436
|
|
G |
Sftpd |
surfactant protein D |
|
ISO |
|
RGD |
PMID:17264398 |
RGD:4143384 |
NCBI chr16:17,046,491...17,058,968
Ensembl chr16:17,046,483...17,059,927
|
|
G |
Tnf |
tumor necrosis factor |
severity no_association |
ISO |
DNA:SNP:promoter:-238A>G (human) DNA:SNP:promoter:-308G>A (human) |
RGD |
PMID:15286263 PMID:15286263 |
RGD:12904049, RGD:12904049 |
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
|
|
G |
Tp53 |
tumor protein p53 |
|
IEP |
|
RGD |
PMID:26431790 |
RGD:11537057 |
NCBI chr10:54,300,070...54,311,525
Ensembl chr10:54,300,048...54,311,524
|
|
G |
Txn1 |
thioredoxin 1 |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:20812253 |
|
NCBI chr 5:72,712,334...72,724,564
Ensembl chr 5:72,711,933...72,724,629
|
|
G |
Vdr |
vitamin D receptor |
susceptibility |
ISO |
associated with Premature Birth;DNA:SNPs: :rs2228570,rs731236(human) |
RGD |
PMID:24796371 |
RGD:13432055 |
NCBI chr 7:128,987,981...129,037,677
Ensembl chr 7:128,987,981...129,037,677
|
|
|
G |
A2m |
alpha-2-macroglobulin |
|
IEP |
|
RGD |
PMID:14960360 |
RGD:1598513 |
NCBI chr 4:154,897,770...154,947,787
Ensembl chr 4:154,897,877...154,947,786
|
|
G |
Alb |
albumin |
disease_progression |
ISO |
|
RGD |
PMID:23917657 |
RGD:11036092 |
NCBI chr14:17,607,397...17,622,814
Ensembl chr14:17,607,381...17,622,836
|
|
G |
Bad |
BCL2-associated agonist of cell death |
|
IEP |
protein:increased expression:neutrophil |
RGD |
PMID:15625305 |
RGD:2292697 |
NCBI chr 1:204,133,502...204,142,829
Ensembl chr 1:204,131,501...204,142,823
|
|
G |
Bax |
BCL2 associated X, apoptosis regulator |
treatment |
IEP |
|
RGD |
PMID:22153006 |
RGD:10054126 |
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
|
|
G |
Bcl2 |
BCL2, apoptosis regulator |
treatment |
IEP |
|
RGD |
PMID:22153006 |
RGD:10054126 |
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
|
|
G |
Becn1 |
beclin 1 |
|
IEP |
|
RGD |
PMID:24730400 |
RGD:11561936 |
NCBI chr10:86,231,387...86,246,742
Ensembl chr10:86,231,388...86,246,742
|
|
G |
Casp3 |
caspase 3 |
treatment |
IEP |
|
RGD |
PMID:22153006 |
RGD:10054126 |
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
|
|
G |
Ccnc |
cyclin C |
|
IEP |
protein:increased expression:skin |
RGD |
PMID:16271231 |
RGD:2315993 |
NCBI chr 5:35,266,828...35,284,943
Ensembl chr 5:35,266,823...35,296,584
|
|
G |
Ccnd1 |
cyclin D1 |
|
IEP |
|
RGD |
PMID:17996899 |
RGD:2289134 |
NCBI chr 1:200,089,002...200,098,524
Ensembl chr 1:200,089,002...200,098,602
|
|
G |
Cd14 |
CD14 molecule |
|
IEP |
mRNA:increased expression:multiple organs: |
RGD |
PMID:11829837 PMID:12435950 |
RGD:7204443, RGD:2313390 |
NCBI chr18:28,335,522...28,337,383
Ensembl chr18:28,335,340...28,337,261
|
|
G |
Cd86 |
CD86 molecule |
|
IEP |
protein:increased expression:spleen, dendritic cell (rat) |
RGD |
PMID:20233162 |
RGD:4892209 |
NCBI chr11:64,142,193...64,200,816
Ensembl chr11:64,163,828...64,200,818
|
|
G |
Cldn1 |
claudin 1 |
|
IEP |
associated with Binge Drinking;protein: decreased tyrosine phosphorylation:intestine mucosa" |
RGD |
PMID:22001439 |
RGD:8655996 |
NCBI chr11:74,421,569...74,436,728
Ensembl chr11:74,421,569...74,436,724
|
|
G |
Cpb2 |
carboxypeptidase B2 |
|
IDA |
protein:increased activity:plasma |
RGD |
PMID:15497025 |
RGD:2313648 |
NCBI chr15:50,557,722...50,606,569
Ensembl chr15:50,557,717...50,606,556
|
|
G |
Crp |
C-reactive protein |
|
IEP |
|
RGD |
PMID:20664819 |
RGD:5131457 |
NCBI chr13:85,131,635...85,175,179
Ensembl chr13:85,124,977...85,175,178
|
|
G |
Cxcl1 |
C-X-C motif chemokine ligand 1 |
|
IEP |
protein:increased expression:serum |
RGD |
PMID:18391855 |
RGD:5135231 |
NCBI chr14:17,193,364...17,195,143
Ensembl chr14:17,193,365...17,195,215
|
|
G |
Cxcl2 |
C-X-C motif chemokine ligand 2 |
|
IEP |
protein:increased expression:serum |
RGD |
PMID:18391855 |
RGD:5135231 |
NCBI chr14:17,181,030...17,183,075
Ensembl chr14:17,181,062...17,183,075
|
|
G |
Cxcl3 |
C-X-C motif chemokine ligand 3 |
|
IEP |
protein:increased expression:serum |
RGD |
PMID:18391855 |
RGD:5135231 |
NCBI chr14:17,270,146...17,289,458
Ensembl chr14:17,270,146...17,289,511
|
|
G |
Dll4 |
delta like canonical Notch ligand 4 |
treatment |
IEP |
|
RGD |
PMID:28319529 |
RGD:155663481 |
NCBI chr 3:106,317,114...106,327,004
Ensembl chr 3:106,316,986...106,326,931
|
|
G |
Eef1a1 |
eukaryotic translation elongation factor 1 alpha 1 |
|
IEP |
protein:decreased expression:heart,mitochondrion: |
RGD |
PMID:23041468 |
RGD:10401126 |
NCBI chr 8:79,341,554...79,344,784
Ensembl chr 8:79,341,557...79,344,839
|
|
G |
Fga |
fibrinogen alpha chain |
|
IEP |
protein:increased expression:plasma (rat) |
RGD |
PMID:20664819 |
RGD:5131457 |
NCBI chr 2:168,365,364...168,381,533
Ensembl chr 2:168,374,120...168,381,528
|
|
G |
Fgfr1 |
Fibroblast growth factor receptor 1 |
|
IEP |
protein:increased expression:epidermis: |
RGD |
PMID:9204964 |
RGD:10402083 |
NCBI chr16:66,492,445...66,546,731
Ensembl chr16:66,494,042...66,547,350
|
|
G |
Fyn |
FYN proto-oncogene, Src family tyrosine kinase |
|
IEP |
protein:decreased phosphorylation, decreased activity:T cell (rat) |
RGD |
PMID:12353920 |
RGD:2324864 |
NCBI chr20:42,767,733...42,960,903
Ensembl chr20:42,766,369...42,959,911
|
|
G |
Grk2 |
G protein-coupled receptor kinase 2 |
|
IEP |
mRNA:increased expression:heart left ventricle (rat) |
RGD |
PMID:29232706 |
RGD:13506829 |
NCBI chr 1:201,581,480...201,601,580
Ensembl chr 1:201,581,480...201,601,582
|
|
G |
Gsk3b |
glycogen synthase kinase 3 beta |
|
IEP |
protein:increased activity,altered phosphorylation:skeletal muscle: |
RGD |
PMID:17686886 |
RGD:10045647 |
NCBI chr11:62,498,997...62,648,665
Ensembl chr11:62,504,316...62,648,646
|
|
G |
Gsta4 |
glutathione S-transferase alpha 4 |
|
ISO |
mRNA:altered expression:fat, muscle, skin (human) mRNA:decreased expression:gastrocnemius muscle (mouse) |
RGD |
PMID:22038048 PMID:22038048 |
RGD:5687774, RGD:5687774 |
NCBI chr 8:79,066,967...79,084,193
Ensembl chr 8:79,066,934...79,084,182
|
|
G |
Hif1a |
hypoxia inducible factor 1 subunit alpha |
|
IEP |
protein:increased expression:Peyer's patches (rat) |
RGD |
PMID:19439119 |
RGD:9068477 |
NCBI chr 6:92,624,059...92,669,262
Ensembl chr 6:92,624,390...92,669,261
|
|
G |
Hmgb1 |
high mobility group box 1 |
treatment |
IEP |
|
RGD |
PMID:20723408 |
RGD:10402183 |
NCBI chr12:5,973,062...5,978,565
Ensembl chr12:5,901,586...5,978,565
|
|
G |
Igf1 |
insulin-like growth factor 1 |
|
IEP |
mRNA:altered expression:multiple |
RGD |
PMID:10827012 |
RGD:12910869 |
NCBI chr 7:22,282,895...22,361,972
Ensembl chr 7:22,282,930...22,359,296
|
|
G |
Igf1r |
insulin-like growth factor 1 receptor |
|
IEP |
protein:decreased expression:skeletal muscle: |
RGD |
PMID:25186839 |
RGD:10046020 |
NCBI chr 1:121,549,839...121,838,545
Ensembl chr 1:121,550,743...121,831,777
|
|
G |
Igfals |
insulin-like growth factor binding protein, acid labile subunit |
|
IEP |
mRNA:decreased expression:liver |
RGD |
PMID:10827012 |
RGD:12910869 |
NCBI chr10:13,897,468...13,903,920
Ensembl chr10:13,898,395...13,902,677
|
|
G |
Igfbp1 |
insulin-like growth factor binding protein 1 |
|
IEP |
mRNA:increased expression:kidney, liver |
RGD |
PMID:10827012 |
RGD:12910869 |
NCBI chr14:82,047,415...82,052,482
Ensembl chr14:82,047,415...82,052,482
|
|
G |
Igfbp3 |
insulin-like growth factor binding protein 3 |
|
IEP |
mRNA:altered expression:kidney, liver, muscle |
RGD |
PMID:10827012 |
RGD:12910869 |
NCBI chr14:82,056,347...82,064,083
Ensembl chr14:82,056,347...82,064,083
|
|
G |
Igfbp7 |
insulin-like growth factor binding protein 7 |
|
IEP |
mRNA:increased expression:liver |
RGD |
PMID:11742840 |
RGD:1626551 |
NCBI chr14:30,737,414...30,797,317
Ensembl chr14:30,737,164...30,797,314
|
|
G |
Il10 |
interleukin 10 |
treatment |
IEP ISO |
CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:18277951 PMID:22341647 |
RGD:11049470 |
NCBI chr13:42,472,625...42,477,308
Ensembl chr13:42,472,839...42,477,313
|
|
G |
Il18 |
interleukin 18 |
|
ISO |
protein:decreased expression:liver |
RGD |
PMID:19197224 |
RGD:4889576 |
NCBI chr 8:50,904,630...50,932,887
Ensembl chr 8:50,906,960...50,932,887
|
|
G |
Il1a |
interleukin 1 alpha |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:10431976 |
|
NCBI chr 3:116,526,601...116,537,055
Ensembl chr 3:116,526,604...116,536,822
|
|
G |
Il1b |
interleukin 1 beta |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18277951 |
|
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
|
|
G |
Il6 |
interleukin 6 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:10431976 PMID:18277951 |
|
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
|
|
G |
Lbp |
lipopolysaccharide binding protein |
|
IEP |
|
RGD |
PMID:12435950 |
RGD:2313390 |
NCBI chr 3:146,953,889...146,981,032
Ensembl chr 3:146,954,015...146,981,586
|
|
G |
Map1lc3a |
microtubule-associated protein 1 light chain 3 alpha |
|
IEP |
|
RGD |
PMID:24730400 |
RGD:11561936 |
NCBI chr 3:143,783,024...143,784,670
Ensembl chr 3:143,783,024...143,784,670
|
|
G |
Mif |
macrophage migration inhibitory factor |
|
IEP |
mRNA, protein:increased expression:liver, serum |
RGD |
PMID:14625478 |
RGD:1642001 |
NCBI chr20:12,790,919...12,791,784
Ensembl chr20:12,790,902...12,799,504
|
|
G |
Mmp7 |
matrix metallopeptidase 7 |
|
IEP |
mRNA:increased expression:ileum |
RGD |
PMID:15182445 |
RGD:9685358 |
NCBI chr 8:4,848,186...4,855,908
Ensembl chr 8:4,848,186...4,855,902
|
|
G |
Mmp9 |
matrix metallopeptidase 9 |
|
IEP |
mRNA, protein:increased expression:brain |
RGD |
PMID:17156757 |
RGD:1642051 |
NCBI chr 3:153,684,158...153,692,118
Ensembl chr 3:153,683,858...153,692,120
|
|
G |
Mpo |
myeloperoxidase |
|
IEP ISO |
protein:increased activity:kidney, lung CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:11996850 PMID:22356815 |
RGD:6909170 |
NCBI chr10:72,594,458...72,608,862
Ensembl chr10:72,594,661...72,604,819
|
|
G |
Mstn |
myostatin |
|
IEP |
mRNA:increased expression:skeletal muscle |
RGD |
PMID:11481237 |
RGD:2303598 |
NCBI chr 9:48,453,982...48,458,809
Ensembl chr 9:48,452,533...48,458,933
|
|
G |
Mt-cyb |
mitochondrially encoded cytochrome b |
|
IDA |
|
RGD |
PMID:3779466 |
RGD:2298976 |
NCBI chr MT:14,136...15,278
Ensembl chr MT:14,136...15,278
|
|
G |
Mtor |
mechanistic target of rapamycin kinase |
|
IDA |
protein:increased serine phosphorylation:skeletal muscle |
RGD |
PMID:20594757 |
RGD:10041043 |
NCBI chr 5:158,884,856...158,994,311
Ensembl chr 5:158,884,804...158,994,311
|
|
G |
Ncf2 |
neutrophil cytosolic factor 2 |
|
IEP |
protein:increased expression:neutrophil |
RGD |
PMID:9329126 |
RGD:2314453 |
NCBI chr13:64,955,502...64,986,289
Ensembl chr13:64,955,503...64,986,277
|
|
G |
Ngf |
nerve growth factor |
|
IMP |
|
RGD |
PMID:12133564 |
RGD:5144074 |
NCBI chr 2:189,901,058...189,954,452
Ensembl chr 2:189,901,058...189,954,452
|
|
G |
Nos2 |
nitric oxide synthase 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15650120 |
|
NCBI chr10:63,815,308...63,851,208
Ensembl chr10:63,815,308...63,851,210
|
|
G |
Nr3c1 |
nuclear receptor subfamily 3, group C, member 1 |
treatment |
IDA IEP |
protein:decreased activity:liver, lung, kidney |
RGD |
PMID:19216853 PMID:11990926 |
RGD:4892319, RGD:7174720 |
NCBI chr18:31,271,681...31,393,320
Ensembl chr18:31,271,681...31,393,375
|
|
G |
Ocln |
occludin |
|
IEP |
associated with Binge Drinking;protein:decreased expression, decreased tyrosine, threonine phosphorylation:intestine mucosa: |
RGD |
PMID:22001439 |
RGD:8655996 |
NCBI chr 2:31,657,217...31,707,466
Ensembl chr 2:31,657,220...31,764,150
|
|
G |
Oxct1 |
3-oxoacid CoA transferase 1 |
|
IEP |
protein:increased expression:ileum (rat) |
RGD |
PMID:15449568 |
RGD:2326198 |
NCBI chr 2:53,236,370...53,384,715
Ensembl chr 2:53,236,368...53,384,714
|
|
G |
Oxt |
oxytocin/neurophysin I prepropeptide |
|
IMP |
|
RGD |
PMID:17826914 |
RGD:2304127 |
NCBI chr 3:117,782,650...117,783,490
Ensembl chr 3:117,782,650...117,783,490
|
|
G |
Pdcd1 |
programmed cell death 1 |
treatment |
ISO |
associated with Pseudomonas Infections; associated with Staphylococcal Infections |
RGD |
PMID:29345058 |
RGD:41410788 |
NCBI chr 9:94,418,786...94,431,945
Ensembl chr 9:94,418,791...94,431,937
|
|
G |
Pde4b |
phosphodiesterase 4B |
|
IEP |
mRNA:increased expression:extensor digitorum longus muscle |
RGD |
PMID:29693432 |
RGD:13782127 |
NCBI chr 5:116,799,827...117,367,707
Ensembl chr 5:116,799,971...117,367,696
|
|
G |
Pklr |
pyruvate kinase L/R |
|
IDA |
|
RGD |
PMID:12417155 |
RGD:1625591 |
NCBI chr 2:174,543,008...174,551,863
Ensembl chr 2:174,543,039...174,551,870
|
|
G |
Pla2g4a |
phospholipase A2 group IVA |
|
IEP |
protein:increased expression:heart |
RGD |
PMID:17483741 |
RGD:1642444 |
NCBI chr13:61,877,818...62,022,261
Ensembl chr13:61,877,813...62,022,266
|
|
G |
Plat |
plasminogen activator, tissue type |
|
ISO |
protein:increased expression:plasma (human) |
RGD |
PMID:11525850 |
RGD:11541048 |
NCBI chr16:69,240,582...69,265,177
Ensembl chr16:69,240,585...69,268,223
|
|
G |
Pomc |
proopiomelanocortin |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:2968671 |
|
NCBI chr 6:26,939,844...26,945,666
Ensembl chr 6:26,939,837...26,945,664
|
|
G |
Prkcd |
protein kinase C, delta |
|
IEP |
protein:altered localization:cardiac muscle cell |
RGD |
PMID:16990486 |
RGD:1642547 |
NCBI chr16:5,769,226...5,807,214
Ensembl chr16:5,769,215...5,799,352
|
|
G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15650120 |
|
NCBI chr13:62,164,080...62,169,770
Ensembl chr13:62,163,932...62,172,188
|
|
G |
Rapgef3 |
Rap guanine nucleotide exchange factor 3 |
treatment |
IDA |
|
RGD |
PMID:24973766 |
RGD:9850087 |
NCBI chr 7:128,875,772...128,898,203
Ensembl chr 7:128,875,773...128,898,521
|
|
G |
Rapgef4 |
Rap guanine nucleotide exchange factor 4 |
treatment |
IDA |
|
RGD |
PMID:24973766 |
RGD:9850087 |
NCBI chr 3:56,809,388...57,101,332
Ensembl chr 3:56,809,270...57,102,316
|
|
G |
Rps6kb1 |
ribosomal protein S6 kinase B1 |
|
IEP |
protein:decreased phosphorylation:heart |
RGD |
PMID:14695116 |
RGD:1643025 |
NCBI chr10:71,323,777...71,367,908
Ensembl chr10:71,323,777...71,367,908
|
|
G |
Serpina1 |
serpin family A member 1 |
|
IEP |
protein:increased expression:serum |
RGD |
PMID:12509927 |
RGD:1643164 |
NCBI chr 6:122,866,314...122,888,339
Ensembl chr 6:122,866,312...122,888,339
|
|
G |
Serping1 |
serpin family G member 1 |
treatment |
ISO |
|
RGD |
PMID:22447201 |
RGD:6903314 |
NCBI chr 3:69,842,726...69,852,583
Ensembl chr 3:69,842,739...69,852,034
|
|
G |
Slc6a4 |
solute carrier family 6 member 4 |
|
IEP |
|
RGD |
PMID:17711618 |
RGD:4889516 |
NCBI chr10:61,824,208...61,858,924
Ensembl chr10:61,826,123...61,858,384
|
|
G |
Socs3 |
suppressor of cytokine signaling 3 |
|
IEP |
mRNA, protein:increased expression:hepatocyte |
RGD |
PMID:12392283 |
RGD:730264 |
NCBI chr10:103,193,909...103,197,322
Ensembl chr10:103,193,537...103,197,787
|
|
G |
Tac1 |
tachykinin, precursor 1 |
|
ISO |
protein:increased expression:plasma, lung |
RGD |
PMID:19797759 |
RGD:5147812 |
NCBI chr 4:35,679,183...35,687,180
Ensembl chr 4:35,679,704...35,687,178
|
|
G |
Tacr1 |
tachykinin receptor 1 |
|
ISO |
mRNA:increased expression:lung |
RGD |
PMID:18523300 |
RGD:5147819 |
NCBI chr 4:114,920,844...115,089,733
Ensembl chr 4:114,920,844...115,089,733
|
|
G |
Tfpi |
tissue factor pathway inhibitor |
|
IEP |
protein:decreased activity:plasma: |
RGD |
PMID:15497025 |
RGD:2313648 |
NCBI chr 3:69,533,156...69,582,547
Ensembl chr 3:69,533,156...69,576,880
|
|
G |
Tnf |
tumor necrosis factor |
treatment |
IDA ISO |
CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:18277951 PMID:26152211 |
RGD:11049530 |
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
|
|
G |
Tnfrsf10b |
TNF receptor superfamily member 10b |
|
IEP |
mRNA, protein:increased expression:thymus |
RGD |
PMID:18019056 |
RGD:2290498 |
NCBI chr15:44,839,818...44,867,582
Ensembl chr15:44,840,386...44,867,467
|
|
G |
Ucn |
urocortin |
|
IEP |
|
RGD |
PMID:16125201 |
RGD:1642782 |
NCBI chr 6:25,238,120...25,238,950
Ensembl chr 6:25,238,120...25,238,950
|
|
G |
Vdac2 |
voltage-dependent anion channel 2 |
|
IEP |
|
RGD |
PMID:23863682 |
RGD:10003047 |
NCBI chr15:2,462,877...2,476,802
Ensembl chr15:2,463,056...2,476,553
|
|
|
G |
Agt |
angiotensinogen |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:33676887 |
|
NCBI chr19:52,529,139...52,549,618
Ensembl chr19:52,529,185...52,540,977
|
|
G |
Bche |
butyrylcholinesterase |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:26145887 |
|
NCBI chr 2:158,308,674...158,401,148
Ensembl chr 2:158,307,584...158,401,148
|
|
G |
Bmp2 |
bone morphogenetic protein 2 |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:29800642 |
|
NCBI chr 3:120,812,660...120,822,579
Ensembl chr 3:120,812,882...120,821,397
|
|
G |
Cat |
catalase |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:35792220 |
|
NCBI chr 3:89,842,393...89,874,577
Ensembl chr 3:89,842,399...89,874,478
|
|
G |
Ccl2 |
C-C motif chemokine ligand 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:29959987 |
|
NCBI chr10:67,005,424...67,007,222
Ensembl chr10:67,005,424...67,007,226
|
|
G |
Csf1 |
colony stimulating factor 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:32068018 |
|
NCBI chr 2:195,377,215...195,396,608
Ensembl chr 2:195,377,215...195,411,704
|
|
G |
Fas |
Fas cell surface death receptor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:34713381 |
|
NCBI chr 1:231,798,963...231,832,591
Ensembl chr 1:231,798,960...231,832,591
|
|
G |
Faslg |
Fas ligand |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:34713381 |
|
NCBI chr13:74,151,519...74,172,760
Ensembl chr13:74,154,954...74,162,215
|
|
G |
Hbegf |
heparin-binding EGF-like growth factor |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:29305325 |
|
NCBI chr18:28,106,284...28,116,167
Ensembl chr18:28,105,760...28,116,441
|
|
G |
Il1b |
interleukin 1 beta |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:32068018 |
|
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
|
|
G |
Mettl14 |
methyltransferase 14, N6-adenosine-methyltransferase subunit |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:34648132 |
|
NCBI chr 2:211,530,598...211,546,858
Ensembl chr 2:211,530,602...211,546,821
|
|
G |
Mir143 |
microRNA 143 |
ameliorates |
ISO |
|
RGD |
PMID:32170053 |
RGD:155883163 |
NCBI chr18:55,101,006...55,101,110
Ensembl chr18:55,101,006...55,101,110
|
|
G |
Mir208a |
microRNA 208a |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:26454886 |
|
NCBI chr15:28,425,570...28,425,652
|
|
G |
Nos3 |
nitric oxide synthase 3 |
treatment |
ISO |
associated with Precursor Cell Lymphoblastic Leukemia-Lymphoma;DNA:polymorphism: :894G>T(human) |
RGD |
PMID:26345518 |
RGD:11533645 |
NCBI chr 4:10,793,834...10,814,170
Ensembl chr 4:10,793,834...10,814,166
|
|
G |
Nppb |
natriuretic peptide B |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:29959987 |
|
NCBI chr 5:158,416,813...158,418,175
Ensembl chr 5:158,416,866...158,418,168
|
|
G |
Nrg1 |
neuregulin 1 |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:29305325 |
|
NCBI chr16:59,250,658...60,303,024
Ensembl chr16:59,250,854...60,296,884
|
|
G |
Rac1 |
Rac family small GTPase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28710503 |
|
NCBI chr12:11,037,028...11,057,251
Ensembl chr12:11,036,698...11,057,251
|
|
G |
Rarg |
retinoic acid receptor, gamma |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:26237429 |
|
NCBI chr 7:133,367,833...133,390,301
Ensembl chr 7:133,367,833...133,390,177
|
|
G |
Sirt6 |
sirtuin 6 |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:34713381 |
|
NCBI chr 7:8,082,312...8,087,776
Ensembl chr 7:8,082,364...8,098,914
|
|
G |
Tlr2 |
toll-like receptor 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:29959987 |
|
NCBI chr 2:169,200,620...169,206,819
Ensembl chr 2:169,197,419...169,206,630
|
|
G |
Tnf |
tumor necrosis factor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:29959987 PMID:32068018 |
|
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
|
|
G |
Tp53 |
tumor protein p53 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:30009776 PMID:34713381 |
|
NCBI chr10:54,300,070...54,311,525
Ensembl chr10:54,300,048...54,311,524
|
|
|
G |
Ldlr |
low density lipoprotein receptor |
|
ISO |
ClinVar Annotator: match by term: Carotid artery dissection |
ClinVar |
PMID:1301956 PMID:2088165 PMID:2318961 PMID:3263645 PMID:8882879 PMID:9157944 PMID:9484998 PMID:10782930 PMID:10978268 PMID:12837857 PMID:16183066 PMID:16250003 PMID:17094996 PMID:17765246 PMID:18677035 PMID:19318025 PMID:20506408 PMID:21310417 PMID:21475731 PMID:21722902 PMID:22390909 PMID:22698793 PMID:23375686 PMID:24033266 PMID:25741868 PMID:27765764 PMID:28492532 PMID:29261184 PMID:29399563 PMID:31345425 More...
|
|
NCBI chr 8:20,270,020...20,292,981
Ensembl chr 8:20,270,041...20,294,580
|
|
G |
Mylk |
myosin light chain kinase |
|
ISO |
ClinVar Annotator: match by term: Carotid artery dissection |
ClinVar |
PMID:25326637 PMID:25741868 PMID:28492532 |
|
NCBI chr11:65,783,008...66,030,239
Ensembl chr11:65,783,008...66,030,261
|
|
|
G |
Ldlr |
low density lipoprotein receptor |
|
ISO |
ClinVar Annotator: match by term: Internal carotid artery dissection |
ClinVar |
PMID:1301956 PMID:2088165 PMID:2318961 PMID:3263645 PMID:8882879 PMID:9157944 PMID:9484998 PMID:10782930 PMID:10978268 PMID:12837857 PMID:16183066 PMID:16250003 PMID:17094996 PMID:17765246 PMID:18677035 PMID:19318025 PMID:20506408 PMID:21310417 PMID:21475731 PMID:21722902 PMID:22390909 PMID:22698793 PMID:23375686 PMID:24033266 PMID:25741868 PMID:27765764 PMID:28492532 PMID:29261184 PMID:29399563 PMID:31345425 More...
|
|
NCBI chr 8:20,270,020...20,292,981
Ensembl chr 8:20,270,041...20,294,580
|
|
G |
Mylk |
myosin light chain kinase |
|
ISO |
ClinVar Annotator: match by term: Internal carotid artery dissection |
ClinVar |
PMID:25326637 PMID:25741868 PMID:28492532 |
|
NCBI chr11:65,783,008...66,030,239
Ensembl chr11:65,783,008...66,030,261
|
|
|
G |
Ager |
advanced glycosylation end product-specific receptor |
|
IMP |
|
RGD |
PMID:21680901 |
RGD:7245963 |
NCBI chr20:4,148,150...4,151,361
Ensembl chr20:4,147,890...4,151,078
|
|
G |
Agtr1a |
angiotensin II receptor, type 1a |
treatment |
IEP |
mRNA:increased expression:artery: |
RGD |
PMID:9918604 |
RGD:10047106 |
NCBI chr17:34,173,446...34,226,892
Ensembl chr17:34,174,429...34,226,946
|
|
G |
Alox12 |
arachidonate 12-lipoxygenase, 12S type |
|
IEP |
|
RGD |
PMID:16118253 |
RGD:5509614 |
NCBI chr10:54,958,263...54,970,542
Ensembl chr10:54,958,271...54,970,542
|
![JBrowse link]() | |